rfhg_90854.1

Basic information about the TSS

---

TSS ID: rfhg_90854.1 Species: human Chr: chr7		Start: 2652575 End: 2652584 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	dELS,CTCF-bound (EH38D3938654,EH38E2529803)
Category:	dELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000498454.1:241 GeneID: 80727 HGNC/MGI_ID: HGNC:22222 UniProt_ID: Nearer transcript ids and distances:

Gene_name: tweety family member 3 Gene_symbol: TTYH3 Gene_synonyms: KIAA1691 Gene_source: HGNC:22222

TATA-Box annotation

---

Distance to TSS:	20593
Nearest PromoterID:	NM_025250
Entrez ID:	80727
Nearest Unigene:	Hs.440899
Nearest Refseq:	NM_025250
Nearest Ensembl:	ENSG00000136295
Gene Name:	tweety family member 3
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.600000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TTYH3 p2@TTYH3 p3@TTYH3 p4@TTYH3 p5@TTYH3 p8@TTYH3 p9@TTYH3 p10@TTYH3
Sample		p1@TTYH3	p2@TTYH3	p3@TTYH3	p4@TTYH3	p5@TTYH3	p8@TTYH3	p9@TTYH3	p10@TTYH3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	9.93	5.26	0.00	0.39	1.56	0.00	0.58	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	8.70	6.47	0.00	0.40	2.23	0.40	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	6.56	5.98	0.00	0.77	0.58	0.19	0.19	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	4.99	6.03	0.00	0.42	1.87	0.42	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	6.97	4.95	0.00	1.12	1.35	0.22	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	5.43	5.23	0.00	0.97	0.78	0.19	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	10.68	6.10	0.00	0.44	0.87	0.00	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	6.54	4.84	0.00	1.70	2.91	0.00	0.48	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.04	7.69	0.00	0.21	3.63	0.21	0.43	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	3.48	4.06	0.00	0.58	0.00	0.00	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	3.23	5.26	0.00	0.40	0.40	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	2.85	4.07	0.00	0.00	0.81	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	17.41	13.22	0.00	0.81	1.13	0.16	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	15.79	7.97	0.00	0.30	0.90	0.60	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	13.39	12.73	0.00	0.22	0.88	0.22	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	13.83	13.83	0.00	1.01	1.01	1.01	0.50	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	12.01	11.58	0.00	0.44	0.66	0.00	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	6.75	5.48	0.00	1.69	0.00	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.53	5.86	0.00	0.00	0.00	0.53	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	16.40	12.34	0.00	1.20	0.90	0.00	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	16.84	16.31	0.00	1.34	1.07	0.27	0.13	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	14.85	16.74	0.00	1.21	0.35	0.52	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	16.03	13.83	0.00	1.16	1.16	0.13	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	18.93	14.80	0.00	1.21	1.70	0.49	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	16.00	20.12	0.00	1.03	2.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	17.41	27.22	0.00	0.63	0.63	0.00	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	12.64	20.88	0.00	0.55	0.55	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	24.75	38.90	0.00	1.18	2.36	0.71	0.24	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	18.58	25.36	0.00	1.29	1.78	0.48	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	20.81	27.87	0.00	1.27	2.53	0.36	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.54	28.47	0.00	2.51	2.09	0.42	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.63	21.30	0.00	1.37	1.76	0.20	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	16.67	23.85	0.00	1.06	2.11	1.06	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	9.24	10.89	0.00	2.80	0.99	0.49	0.66	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	18.32	26.18	0.00	2.06	1.87	0.75	1.50	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	19.16	37.75	0.00	0.96	2.30	0.38	0.57	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	21.26	29.02	0.00	1.64	2.25	0.20	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.75	30.83	0.00	2.42	1.41	0.81	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	21.07	32.95	0.00	2.43	3.78	1.08	0.54	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	18.96	26.41	0.00	1.68	2.40	0.24	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	18.59	28.94	0.00	2.59	2.12	0.47	1.18	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	10.98	10.10	0.00	0.88	1.46	0.29	0.73	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	22.99	33.74	0.00	1.48	1.05	0.42	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	19.76	27.97	0.00	1.22	2.45	0.17	0.52	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	19.27	32.32	0.00	1.00	3.01	0.20	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	18.38	33.73	0.00	1.63	3.02	1.16	0.23	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	20.63	35.99	0.00	0.96	2.88	0.96	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	16.69	28.02	0.00	1.79	4.17	0.89	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	16.04	36.62	0.00	0.48	0.72	0.24	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	18.20	22.85	0.00	1.62	2.02	0.20	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	17.01	20.09	0.00	0.61	1.23	0.82	1.43	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	25.57	26.02	0.00	2.00	3.11	0.67	0.44	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	13.99	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.77	19.87	0.00	0.71	3.55	0.00	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	13.26	24.85	0.00	1.33	2.65	0.99	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	5.03	0.84	0.00	6.71	0.00	1.68	1.68	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.27	3.67	0.00	2.30	0.46	0.46	2.30	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	18.47	22.69	0.00	0.65	3.24	0.97	0.97	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	19.27	27.94	0.00	1.61	1.28	0.32	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	9.74	4.71	0.00	1.57	1.57	0.31	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	13.40	18.33	0.00	0.00	0.71	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.78	16.26	0.00	1.68	1.68	1.12	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.96	0.80	0.00	3.18	0.80	1.59	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	9.51	5.10	0.00	0.00	1.02	0.68	0.68	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	15.27	17.55	0.00	0.65	2.27	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	15.97	12.07	0.00	1.77	2.48	0.35	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.31	4.88	0.00	0.98	0.00	0.00	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	15.37	12.89	0.00	0.00	1.49	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	4.22	6.10	0.00	0.00	0.47	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	8.28	3.97	0.00	0.33	0.33	0.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	11.45	10.52	0.00	0.62	0.62	0.31	0.62	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.56	10.40	0.00	0.31	0.92	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	10.29	15.05	0.00	0.63	0.48	0.79	0.63	0.48
Adipocyte - breast, donor2	11327-117E4	11.23	14.44	0.00	1.93	0.32	0.96	1.44	1.12
Adipocyte - omental, donor1	11473-119C6	9.54	12.34	0.00	2.42	0.38	0.25	0.25	0.13
Adipocyte - omental, donor2	11474-119C7	6.73	14.95	0.00	0.75	1.49	0.00	2.24	0.00
Adipocyte - omental, donor3	11475-119C8	7.70	8.71	0.00	0.67	0.33	0.67	1.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	6.38	11.48	0.00	1.91	1.28	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	0.00	0.00	3.30	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	12.65	15.36	0.00	3.16	1.35	0.00	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	7.65	9.91	0.00	1.22	1.22	0.52	0.00	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	45.18	49.68	0.00	2.54	1.76	1.17	0.59	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	31.40	38.09	0.00	1.80	2.06	0.77	1.03	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	30.11	30.66	0.00	1.39	1.39	0.56	1.12	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	22.34	30.57	0.00	0.00	1.18	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	18.82	25.50	0.00	2.17	1.37	0.24	0.32	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	20.66	27.76	0.00	1.61	0.97	0.65	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	13.86	14.93	0.00	0.53	0.00	0.53	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	14.47	20.59	0.00	2.23	0.56	0.00	1.67	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	11.23	21.63	0.00	0.83	0.83	0.42	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	19.34	31.40	0.00	1.76	1.76	0.50	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	9.16	15.38	0.00	0.98	0.98	0.33	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	11.87	17.05	0.00	0.00	0.00	0.61	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	33.59	14.81	0.00	0.88	1.33	0.22	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	31.91	22.59	0.00	3.23	0.72	1.43	1.08	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	31.15	11.98	0.00	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	27.17	6.12	0.00	0.90	0.72	0.36	0.00	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	31.80	8.37	0.00	0.00	1.67	3.35	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	50.33	10.07	0.00	1.44	0.82	0.41	1.23	0.62
Anulus Pulposus Cell, donor1	11248-116E6	20.94	12.59	0.00	1.26	1.83	0.34	0.46	1.14
Anulus Pulposus Cell, donor2	11463-119B5	17.88	17.39	0.00	0.49	2.94	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	18.42	11.23	0.00	2.70	0.90	1.35	2.25	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	21.71	22.14	0.00	3.04	1.30	0.43	1.74	3.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	14.98	0.00	2.14	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	23.02	23.61	0.00	3.59	2.09	1.79	1.20	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	29.09	30.35	0.00	7.59	1.26	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	16.50	30.36	0.00	0.66	0.66	1.98	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	21.44	23.39	0.00	2.27	1.30	0.32	0.65	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	25.24	22.33	0.00	4.37	0.97	0.97	1.46	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	16.63	20.19	0.00	2.97	1.78	2.38	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.81	20.34	0.00	2.26	1.13	1.88	1.13	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	20.32	18.14	0.00	2.18	0.00	0.73	2.18	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	22.57	23.82	0.00	3.76	0.00	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	22.40	32.12	0.00	0.99	1.48	0.33	0.49	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	24.57	20.47	0.00	5.46	0.00	1.36	1.36	4.09
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	30.01	37.25	0.00	0.45	1.81	0.60	0.45	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	25.72	28.93	0.00	2.68	2.14	1.07	2.14	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	22.48	28.34	0.00	2.46	1.13	0.57	0.38	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	20.31	32.34	0.00	2.94	0.53	1.34	0.53	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	23.41	29.26	0.00	1.95	0.98	0.00	1.95	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	22.56	30.35	0.00	1.49	1.66	0.66	0.83	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	25.22	0.00	2.40	1.20	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	60.18	0.00	3.54	0.00	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	25.21	36.36	0.00	1.72	1.37	1.54	1.03	1.72
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	33.56	0.00	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	18.45	26.70	0.00	3.88	1.94	1.94	1.46	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	20.11	28.08	0.00	1.90	2.66	0.38	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	24.23	35.13	0.00	2.42	2.42	2.42	1.21	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	21.09	22.23	0.00	1.14	2.85	0.57	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	22.45	31.42	0.00	1.28	2.35	1.28	0.21	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	20.91	27.87	0.00	1.29	1.81	0.52	0.26	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	19.24	18.77	0.00	1.88	0.94	1.88	1.88	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	26.05	33.12	0.00	1.61	1.93	1.61	0.64	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	18.55	27.11	0.00	1.43	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	22.81	16.96	0.00	1.75	0.58	0.58	1.17	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	17.46	29.51	0.00	1.51	1.51	0.60	0.90	1.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	26.14	28.51	0.00	1.19	0.00	0.00	2.38	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	24.41	12.21	0.00	2.03	0.51	0.51	0.51	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	29.03	22.67	0.00	2.29	1.02	0.76	0.76	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.25	24.14	0.00	1.27	0.64	1.27	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	20.71	18.56	0.00	1.29	1.73	1.73	0.86	2.16
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	25.19	27.52	0.00	1.69	1.69	1.27	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	18.56	24.36	0.00	0.87	0.87	1.45	0.58	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	26.45	21.73	0.00	3.78	0.94	1.89	1.89	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	22.72	30.18	0.00	1.86	1.02	0.85	0.68	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	27.80	6.95	0.00	6.95	2.32	0.00	4.63	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	29.58	0.00	0.00	4.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	23.16	36.02	0.00	2.57	2.14	0.86	0.86	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	14.44	27.07	0.00	3.61	1.20	1.20	0.00	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	14.58	21.87	0.00	2.92	0.73	0.73	0.73	2.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	22.07	29.42	0.00	2.99	2.53	0.46	1.61	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	25.50	0.00	7.65	0.00	2.55	0.00	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	17.54	35.34	0.00	1.02	1.53	0.25	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	24.57	32.82	0.00	1.45	2.06	0.41	1.03	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	21.73	30.29	0.00	0.61	2.45	0.92	1.22	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	20.08	13.86	0.00	3.35	0.48	1.43	1.43	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	29.49	34.81	0.00	2.66	3.33	2.66	2.22	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	25.94	0.00	1.53	1.53	1.53	3.05	4.58
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	18.83	16.62	0.00	1.11	2.22	0.55	2.22	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	21.45	30.72	0.00	3.18	1.32	0.79	1.32	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	19.99	32.35	0.00	1.09	1.82	0.73	0.73	0.73
Astrocyte - cerebellum, donor1	11500-119F6	38.44	50.11	0.00	3.81	4.54	1.23	1.35	1.23
Astrocyte - cerebellum, donor2	11580-120F5	39.37	52.37	0.00	3.59	3.25	1.20	0.68	1.37
Astrocyte - cerebellum, donor3	11661-122F5	45.72	49.08	0.00	2.52	2.73	1.47	0.63	1.47
Astrocyte - cerebral cortex, donor1	11235-116D2	39.39	42.88	0.00	1.39	5.23	1.39	0.70	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	52.90	39.80	0.00	3.07	3.72	0.97	1.46	1.78
Astrocyte - cerebral cortex, donor3	11392-118C6	75.62	69.36	0.00	2.09	4.33	1.19	1.49	2.39
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	25.23	30.05	0.00	3.78	2.29	1.49	0.80	0.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	23.93	34.83	0.00	3.76	2.51	1.00	1.00	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	21.05	25.95	0.00	2.28	1.59	1.48	0.68	1.02
Basophils, donor1	12241-129G9	22.23	17.26	0.00	0.26	1.83	0.26	0.00	0.00
Basophils, donor2	12242-129H1	19.84	9.74	0.00	0.00	0.72	0.00	0.00	0.36
Basophils, donor3	12243-129H2	50.86	41.45	0.00	0.73	2.20	0.29	0.59	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	12.72	8.19	0.00	0.86	1.08	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	26.06	33.37	0.00	0.91	0.91	0.91	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	0.00	0.00	0.00	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	10.04	16.95	0.00	1.88	2.51	0.00	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	19.34	22.04	0.00	1.04	1.46	0.21	0.21	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	9.90	8.29	0.00	0.00	0.00	0.23	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	12.60	4.68	0.00	1.44	0.36	0.00	0.36	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	2.47	1.24	0.00	0.10	0.00	0.00	0.21	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	1.40	0.23	0.00	0.00	0.00	0.00	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	28.14	1.28	0.00	0.96	0.64	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	74.39	39.45	0.00	0.56	5.07	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	56.42	41.20	0.00	2.60	1.67	1.30	0.74	0.19
CD14+ Monocytes, donor3	11381-118B4	64.76	51.81	0.22	0.44	2.63	0.66	0.22	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	111.80	127.65	0.00	7.64	1.98	1.13	1.98	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	87.95	161.11	0.00	6.44	1.14	1.14	2.65	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	108.16	201.85	0.00	9.86	1.64	2.30	3.94	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	51.46	42.21	0.00	3.76	2.60	1.30	1.59	2.02
CD14+ monocytes - mock treated, donor2	11873-125C1	31.08	28.67	0.00	0.91	3.32	0.00	2.11	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	36.24	35.06	0.00	1.42	1.90	0.47	1.18	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	37.83	42.69	0.00	2.18	1.84	1.17	1.51	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	28.15	34.50	0.00	2.21	3.31	0.28	1.66	1.93
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	31.98	46.61	0.00	1.49	1.24	0.74	0.25	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	30.94	34.46	0.00	1.37	0.78	1.17	0.98	1.96
CD14+ monocytes - treated with BCG, donor2	11870-125B7	32.94	30.62	0.00	1.42	2.49	0.36	0.53	0.89
CD14+ monocytes - treated with BCG, donor3	11880-125C8	28.07	21.76	0.22	1.31	1.74	0.44	0.87	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	35.59	33.95	0.00	2.34	0.23	0.70	0.00	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	29.04	33.79	0.00	1.58	0.53	0.00	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	38.83	31.06	0.00	1.11	4.44	1.11	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	41.50	42.69	0.00	4.31	3.42	1.78	2.83	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	28.34	33.32	0.00	2.20	1.80	0.40	0.80	2.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	18.11	25.40	0.00	0.42	1.04	0.21	0.00	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	36.61	34.09	0.00	4.12	1.83	1.60	1.14	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	27.37	25.11	0.00	0.90	1.81	0.68	0.45	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	20.08	32.30	0.00	1.31	1.75	0.44	0.44	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	36.04	22.60	0.00	3.23	1.34	0.81	1.08	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	36.29	25.30	0.00	1.92	2.44	0.17	1.05	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	35.35	31.56	0.00	2.52	1.68	0.42	2.52	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	26.64	22.05	0.00	2.20	1.47	0.92	0.55	1.84
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	25.72	29.24	0.00	0.70	0.70	0.35	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	20.18	17.11	0.00	0.44	2.19	0.44	0.44	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	38.19	44.64	0.00	1.74	2.44	1.22	1.22	1.22
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	39.40	38.65	0.00	0.00	1.86	0.74	1.12	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	37.72	29.75	0.00	1.08	2.16	0.86	0.43	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	31.12	24.98	0.00	1.64	1.23	1.64	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	16.69	11.59	0.00	0.46	2.09	0.00	0.70	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	15.54	19.72	0.00	0.93	0.46	0.23	0.70	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	18.09	36.40	0.00	0.87	1.74	0.44	1.09	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	26.56	44.12	0.23	0.46	2.54	1.85	0.46	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	25.34	40.72	0.00	0.87	1.73	0.00	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	35.97	30.21	0.00	1.09	1.87	0.00	0.47	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	26.55	25.15	0.00	0.52	2.27	0.00	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	26.76	20.29	0.00	1.34	1.11	0.00	1.11	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	26.79	52.82	0.26	1.02	2.81	0.51	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	21.52	38.42	0.00	0.88	2.85	0.44	0.44	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	22.74	54.11	0.00	0.21	2.53	0.42	0.21	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	2.03	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	4.07	1.36	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	5.18	1.04	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	10.66	6.40	0.00	0.53	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	7.50	1.61	0.00	0.00	0.00	0.00	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	2.81	1.40	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	4.71	2.35	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	2.64	0.00	0.00	0.00	1.32	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	4.93	4.93	0.00	0.82	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	6.53	7.98	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	7.07	3.53	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.00	0.00	0.00	0.81	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	28.11	5.02	1.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	13.48	6.74	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	26.30	3.76	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	13.75	2.25	0.00	0.00	0.23	0.23	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	5.00	2.14	0.00	0.00	0.00	0.00	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	4.90	0.61	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	3.66	0.30	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	2.55	1.28	0.00	0.26	0.26	0.26	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	2.02	2.70	0.00	0.22	0.22	0.00	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	6.32	4.02	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	2.37	0.47	0.00	0.00	0.47	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	3.32	0.58	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	3.56	3.22	0.00	0.17	0.17	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	2.90	2.74	0.00	0.16	0.16	0.32	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	2.69	0.45	0.00	0.00	0.00	0.00	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.70	0.35	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	4.40	0.44	0.00	0.44	1.32	0.00	0.00	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	5.48	2.11	0.00	0.84	0.42	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	8.10	7.06	0.00	0.42	0.42	0.00	0.21	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	7.35	3.34	0.00	0.33	0.67	0.00	0.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	3.54	1.63	0.00	0.00	0.27	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	2.68	2.14	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	5.38	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	3.71	1.48	0.00	0.19	0.00	0.19	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	3.68	1.08	0.00	0.00	0.22	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	2.31	0.21	0.00	0.21	0.21	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	2.02	0.51	0.00	0.51	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.43	0.43	0.00	0.00	0.43	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	5.94	2.47	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	6.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	5.82	1.94	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	3.44	2.45	0.00	0.00	0.25	0.25	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	6.16	3.08	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	3.94	2.15	0.00	0.00	0.36	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	2.77	0.00	0.00	0.00	0.00	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	3.60	0.65	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	4.13	0.75	0.00	0.75	0.00	0.38	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	4.80	2.78	0.00	0.25	0.50	0.00	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	8.49	14.68	0.00	0.00	1.15	0.69	0.23	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	7.19	10.78	0.00	1.20	1.20	1.20	0.24	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	5.20	11.49	0.00	0.82	0.82	0.00	0.82	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3.60	5.10	0.00	1.80	0.30	0.30	0.60	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	8.64	14.40	0.00	0.72	0.96	0.48	0.00	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	9.55	13.19	0.00	0.91	0.23	0.91	0.91	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	7.39	16.73	0.00	1.09	1.96	1.09	0.43	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	5.79	22.11	0.00	0.79	1.05	0.26	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	9.62	19.93	0.00	1.17	1.64	0.23	0.94	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	9.96	15.09	0.00	1.51	1.51	0.60	0.00	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	9.30	14.82	0.00	0.87	1.45	1.45	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	11.46	17.32	0.00	0.27	1.60	0.27	0.27	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	10.07	45.53	0.00	0.00	2.19	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	9.56	47.36	0.00	0.00	0.91	0.00	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	8.20	52.96	0.00	0.75	1.49	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	6.84	17.29	0.00	0.72	0.72	0.36	0.36	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	9.21	15.54	0.00	1.15	1.44	0.86	0.58	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	6.13	18.62	0.00	1.41	0.47	0.47	0.47	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	7.61	19.33	0.32	0.00	1.90	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	8.30	19.38	0.00	0.31	2.15	0.00	0.00	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	6.41	13.46	0.00	0.96	0.64	0.32	1.28	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	7.27	12.62	0.00	1.53	1.53	0.38	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	5.12	15.37	0.00	0.79	1.18	1.18	0.00	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	6.81	8.32	0.00	1.51	0.76	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	8.83	40.95	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	4.90	34.97	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	10.02	46.08	0.00	1.00	1.00	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	12.79	3.66	0.00	1.83	0.00	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	20.26	7.91	0.00	0.99	1.48	0.49	0.00	1.48
Cardiac Myocyte, donor3	11686-122I3	21.05	8.52	0.00	0.63	0.63	0.00	0.21	0.21
Chondrocyte - de diff, donor1	11261-116G1	7.97	16.64	0.00	1.73	0.69	0.00	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	14.22	13.15	0.00	1.42	0.71	0.71	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	10.35	10.70	0.00	1.14	0.57	0.11	0.80	0.68
Chondrocyte - re diff, donor2	11339-117F7	7.16	8.95	0.00	0.00	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	8.90	7.28	0.00	0.40	0.40	0.00	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	52.33	33.51	0.00	2.07	2.98	1.49	0.92	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	44.89	37.41	0.00	3.63	1.28	1.92	0.64	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	55.22	36.99	0.00	2.83	2.04	0.97	0.97	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	18.43	38.70	0.00	2.93	2.11	0.73	0.92	0.92
Corneal Epithelial Cells, donor1	11526-119I5	21.08	15.15	0.00	1.10	0.22	0.22	0.44	0.66
Corneal Epithelial Cells, donor2	11606-120I4	6.83	9.10	0.00	1.14	0.00	1.14	3.41	0.00
Corneal Epithelial Cells, donor3	11687-122I4	11.50	9.46	0.26	0.77	0.51	0.26	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	37.81	103.35	0.00	1.98	2.97	0.83	0.50	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	41.32	109.45	0.00	2.52	5.05	0.32	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	31.06	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	38.88	113.61	0.00	4.64	4.32	2.70	1.62	1.94
Dendritic Cells - plasmacytoid, donor1	11228-116C4	16.06	7.86	0.00	0.68	1.02	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	7.83	1.96	0.00	0.00	0.00	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	14.52	7.74	0.00	0.00	2.42	0.00	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	43.36	31.85	0.00	2.17	2.84	1.00	0.67	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	35.79	32.27	0.00	0.59	1.17	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	54.30	50.62	0.00	2.55	4.24	0.85	1.13	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	30.28	44.43	0.00	3.15	2.36	0.39	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	49.74	50.03	0.00	6.40	3.49	1.45	0.87	2.33
Endothelial Cells - Artery, donor2	11341-117F9	53.41	44.00	0.00	7.06	1.88	2.59	1.41	1.41
Endothelial Cells - Artery, donor3	11413-118E9	52.59	48.21	0.00	4.73	3.86	1.40	1.23	1.75
Endothelial Cells - Lymphatic, donor1	11236-116D3	37.02	34.13	0.00	1.33	2.88	0.44	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	38.64	53.25	0.00	0.91	3.04	0.91	0.61	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	35.24	36.65	0.00	0.56	0.85	0.85	1.13	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	23.18	25.85	0.00	4.75	0.89	0.30	0.89	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	27.07	27.60	0.00	1.56	3.12	0.00	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	47.92	28.78	0.14	4.40	2.98	1.28	1.56	1.99
Endothelial Cells - Thoracic, donor1	11266-116G6	25.21	36.01	0.00	4.40	2.40	0.80	0.00	2.40
Endothelial Cells - Thoracic, donor2	11343-117G2	63.42	64.47	0.00	5.24	4.19	1.57	1.57	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	46.22	21.87	0.00	3.11	1.86	0.25	0.75	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	44.97	21.29	0.00	0.87	0.87	0.43	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	41.89	17.95	0.00	0.61	0.85	0.49	0.49	0.49
Endothelial Cells - Vein, donor1	11267-116G7	64.84	53.46	0.00	3.41	4.55	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	52.39	51.69	0.00	5.59	4.19	0.70	2.10	1.40
Endothelial Cells - Vein, donor3	11416-118F3	71.91	37.37	0.00	1.41	1.57	0.47	0.79	1.57
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	29.70	6.60	0.00	1.65	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	14.27	10.70	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	16.37	10.99	0.00	1.47	1.47	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	4.16	0.00	0.00	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	16.42	14.37	0.00	0.00	1.64	0.41	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.87	13.80	0.00	1.42	0.99	0.44	1.20	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.32	10.62	0.00	1.30	0.54	0.22	0.54	0.87
Fibroblast - Aortic Adventitial, donor1	11245-116E3	24.50	21.35	0.00	3.27	1.94	0.85	0.24	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	12.56	17.47	0.00	0.68	2.05	0.00	0.14	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	30.80	37.34	0.00	6.22	2.43	1.58	2.11	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	17.92	28.19	0.00	6.06	4.74	1.05	0.79	1.84
Fibroblast - Aortic Adventitial, donor3	11401-118D6	32.56	32.56	0.00	2.99	2.33	1.66	1.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	27.22	16.33	0.00	2.27	0.45	0.91	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	50.78	30.32	0.00	3.03	2.27	0.76	0.00	1.52
Fibroblast - Cardiac, donor3	11417-118F4	40.22	34.70	0.00	5.52	2.52	1.26	1.26	1.42
Fibroblast - Cardiac, donor4	11452-119A3	30.31	23.64	0.00	0.91	2.42	0.00	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	17.77	24.75	0.00	2.41	3.81	0.63	0.76	0.63
Fibroblast - Cardiac, donor6	11460-119B2	23.35	28.80	0.00	2.27	2.88	0.76	0.15	1.21
Fibroblast - Choroid Plexus, donor1	11492-119E7	24.39	36.98	0.00	1.47	3.48	0.67	0.54	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	24.59	21.14	0.00	0.86	1.29	0.43	0.43	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	45.41	10.25	0.00	2.93	0.00	2.93	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	29.75	15.22	0.00	0.00	2.54	0.00	0.46	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	26.80	15.60	0.00	0.68	1.36	0.17	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	8.92	8.22	0.00	1.41	1.41	0.23	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	13.68	8.49	0.00	1.89	1.89	0.47	0.47	1.89
Fibroblast - Dermal, donor3	11418-118F5	14.99	10.15	0.00	1.57	1.09	0.12	0.12	0.48
Fibroblast - Dermal, donor4	11450-119A1	14.92	7.91	0.00	0.57	0.57	0.68	0.34	0.45
Fibroblast - Dermal, donor5	11454-119A5	16.75	9.94	0.00	1.22	0.87	0.52	0.00	0.70
Fibroblast - Dermal, donor6	11458-119A9	19.82	13.32	0.00	1.62	2.27	0.81	0.81	0.97
Fibroblast - Gingival, donor1	11237-116D4	13.74	13.53	0.00	0.21	1.46	0.42	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	20.70	17.03	0.00	1.57	1.31	0.00	0.26	0.26
Fibroblast - Gingival, donor2	11318-117D4	31.50	16.34	0.00	2.77	1.32	0.92	0.66	0.92
Fibroblast - Gingival, donor3	11394-118C8	21.37	19.72	0.00	2.03	1.74	0.58	0.77	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	22.86	32.21	0.00	2.08	5.19	0.00	2.08	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	15.68	15.33	0.00	3.52	2.11	1.06	1.06	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	22.45	20.42	0.00	0.94	1.40	0.62	0.47	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	15.82	15.01	0.00	2.03	0.54	0.81	2.03	1.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	56.11	47.99	0.00	4.23	2.47	1.06	1.76	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	17.55	18.43	0.00	1.61	0.88	0.73	0.44	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	14.32	17.73	0.00	0.95	1.23	0.68	0.68	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	16.34	16.45	0.00	1.10	0.88	0.66	0.11	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	30.37	31.70	0.00	5.58	2.49	1.17	0.73	1.03
Fibroblast - Lung, donor1	11270-116H1	32.62	12.23	0.00	0.00	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	37.30	13.43	0.00	0.00	0.00	1.49	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	33.98	15.19	0.00	2.32	2.95	0.42	0.63	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	16.66	15.83	0.00	2.50	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	5.59	0.00	2.80	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	22.11	15.67	0.00	1.40	0.56	0.56	0.84	0.28
Fibroblast - Mammary, donor1	11540-120B1	25.98	18.67	0.00	1.62	2.03	0.81	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	27.96	11.98	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	17.87	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	30.26	8.92	0.00	1.94	1.75	0.78	0.19	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	42.32	24.88	0.00	3.19	1.97	2.28	1.52	1.82
Fibroblast - Periodontal Ligament, donor3	11395-118C9	16.52	13.46	0.00	0.61	0.92	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	20.99	20.23	0.00	0.38	0.76	0.38	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	18.09	14.58	0.00	1.35	1.08	0.00	0.54	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.28	17.51	0.00	1.16	1.16	0.58	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	18.90	12.71	0.00	0.88	1.33	0.33	0.33	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	34.34	24.38	0.00	2.03	1.42	0.61	0.41	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	30.74	16.04	0.00	1.34	2.00	0.00	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	19.77	10.28	0.00	1.19	1.58	0.00	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	19.45	14.69	0.00	2.98	0.79	0.60	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	15.45	20.78	0.00	1.07	2.31	0.36	0.36	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	17.34	24.64	0.00	1.77	1.38	0.39	1.77	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	15.95	16.85	0.00	1.20	1.50	0.00	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	15.01	18.14	0.00	1.84	0.54	0.54	0.76	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	7.34	10.38	0.00	1.27	0.76	1.01	0.51	0.76
Fibroblast - skin normal, donor1	11553-120C5	15.92	12.96	0.00	1.31	1.15	0.16	0.33	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	24.26	18.65	0.00	1.60	1.00	0.40	0.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	12.56	17.58	0.00	1.61	0.30	0.20	0.60	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	15.11	18.13	0.00	1.51	1.21	0.60	0.30	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	22.45	27.84	0.00	2.15	1.66	0.50	0.75	0.75
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	9.40	14.19	0.00	2.56	1.37	0.00	0.68	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	18.06	15.11	0.00	1.97	0.66	0.33	0.33	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	10.01	13.42	0.00	1.28	1.60	0.85	0.85	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	28.00	22.43	0.00	1.86	1.69	0.17	0.51	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.43	3.29	0.00	2.20	0.47	0.63	1.88	1.25
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	2.61	6.10	0.00	0.00	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	21.84	21.84	0.00	2.43	1.39	0.35	0.69	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	21.86	25.76	0.00	0.78	0.52	0.26	0.52	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	20.19	20.44	0.00	1.02	1.02	0.51	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	38.28	6.89	0.00	4.59	1.53	0.77	0.00	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	22.33	7.66	0.00	1.91	1.28	0.64	0.64	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	38.80	11.98	0.00	2.28	3.42	0.86	0.00	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	66.73	27.30	0.00	8.00	3.86	2.21	1.38	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	77.40	29.91	0.00	1.37	2.28	0.68	2.28	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	51.32	27.14	0.00	3.37	3.57	1.39	0.99	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	67.41	22.20	0.00	6.87	3.44	0.79	2.64	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	62.29	29.03	0.00	3.91	5.54	0.65	1.30	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	25.65	14.59	0.00	2.65	3.98	0.88	0.88	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	28.55	11.59	0.00	2.12	3.39	1.27	0.99	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	44.82	18.23	0.00	2.59	2.46	0.74	0.99	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	19.88	9.94	0.00	1.61	3.49	0.54	1.07	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	64.05	25.03	0.00	5.08	2.23	1.12	0.99	1.73
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	38.48	20.63	0.00	2.35	2.35	2.21	1.52	1.38
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	20.13	13.21	0.00	2.03	1.02	1.02	0.41	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	50.66	31.95	0.68	5.70	2.51	1.14	1.60	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	50.32	26.16	0.00	2.49	4.24	1.74	0.87	1.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	39.78	19.67	0.00	2.62	1.75	1.31	1.31	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	63.23	23.93	1.48	5.32	2.95	1.48	1.18	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	58.97	35.45	0.79	6.04	3.97	0.95	1.75	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	44.68	25.02	0.00	3.57	1.56	0.89	1.34	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	67.14	33.07	3.23	8.87	3.23	4.44	3.43	3.83
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	66.33	71.08	5.26	8.31	2.88	2.37	1.53	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	59.77	100.11	8.25	11.62	4.52	1.77	2.48	1.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	150.36	112.38	23.72	29.97	4.06	1.35	6.56	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	115.62	91.37	19.81	20.32	3.76	1.71	3.24	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	98.04	147.94	12.95	11.95	4.09	3.43	2.99	3.32
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	69.97	172.38	26.54	14.48	4.33	2.08	3.33	2.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	60.23	178.86	27.16	13.07	3.88	1.84	3.47	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	76.13	58.80	10.93	9.08	1.65	2.48	3.51	3.09
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	115.29	118.41	13.03	11.53	4.15	2.88	3.57	2.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	100.73	302.18	56.20	21.51	6.67	7.34	6.17	5.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	86.41	56.21	10.36	11.90	3.09	2.87	3.75	3.53
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	118.93	115.24	14.76	16.48	3.69	3.32	4.06	3.07
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	96.77	237.95	68.57	17.51	4.21	5.19	4.54	5.84
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	107.76	73.76	17.00	14.11	2.25	3.85	3.85	3.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	110.01	156.25	25.20	16.01	5.78	4.17	3.41	3.98
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	131.92	344.98	111.83	26.73	6.01	7.75	7.43	7.75
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	81.19	100.96	22.81	25.24	3.95	6.08	4.87	5.17
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	105.27	118.02	14.74	11.50	3.76	4.81	3.66	2.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	126.02	330.65	136.34	24.37	7.25	7.25	7.25	7.25
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	88.09	106.33	20.20	16.27	4.21	5.33	6.73	3.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	89.62	267.02	27.22	10.09	8.43	2.50	4.17	3.70
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	96.00	559.94	114.45	36.63	5.88	9.89	10.16	13.64
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	85.99	207.63	41.92	12.24	7.04	3.52	4.74	4.74
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	96.76	320.86	38.73	19.43	6.74	4.53	4.92	6.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	134.18	648.68	159.39	37.14	9.22	8.13	8.95	8.40
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	94.76	156.70	20.09	15.49	4.06	6.64	4.79	5.53
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	98.69	170.84	12.06	13.60	4.17	6.58	4.82	5.48
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	216.20	820.17	320.33	77.36	15.87	15.87	16.86	13.88
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	83.10	131.91	15.17	12.80	4.22	3.43	3.69	4.22
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	76.47	113.79	14.53	8.27	2.62	1.61	3.43	4.44
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	158.09	319.99	152.75	34.31	7.37	2.29	7.37	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	12.74	9.75	0.00	1.99	1.59	0.20	1.19	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	22.96	11.40	0.00	2.62	1.39	0.77	1.08	1.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	30.89	14.12	0.00	0.82	1.84	0.61	0.20	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	29.10	22.84	0.00	1.88	2.82	0.63	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	24.30	11.02	0.00	0.57	2.26	0.57	0.28	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	21.22	12.91	0.00	1.38	3.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	32.17	24.75	0.00	4.95	4.95	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	22.43	19.73	0.00	3.48	5.03	1.55	0.00	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	11.23	0.00	0.00	4.81	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	43.47	26.08	0.00	0.00	6.96	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	29.29	14.97	0.00	3.58	2.93	1.63	0.65	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	21.41	14.00	0.00	4.12	1.24	2.06	0.00	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	6.66	0.00	6.66	3.33	3.33	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	22.37	13.70	0.00	4.19	2.24	0.84	0.28	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	30.40	12.42	0.00	5.56	1.96	1.31	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	54.52	24.33	0.00	3.36	3.36	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	34.99	15.59	0.00	2.86	2.54	1.27	1.27	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	29.89	14.95	0.00	1.36	1.36	1.70	1.36	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	10.44	0.00	2.09	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	45.24	16.61	0.00	4.01	0.57	1.72	0.57	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	37.00	13.32	0.00	1.78	2.07	0.59	1.48	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	38.97	22.02	0.00	0.00	3.39	3.39	1.69	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	26.10	14.91	0.00	3.73	0.83	1.66	0.83	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	34.29	14.27	0.00	5.29	3.91	0.46	0.69	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	26.34	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	38.06	12.69	0.00	1.92	2.31	0.77	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	22.17	10.43	0.00	2.93	2.28	0.98	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	31.44	11.37	0.00	3.34	0.67	0.67	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	48.54	7.71	0.00	4.62	0.39	1.54	0.39	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	49.30	8.56	0.00	5.82	1.37	0.34	0.68	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	59.63	39.76	0.00	9.94	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	57.09	15.10	0.00	5.19	1.89	1.89	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	41.64	10.26	0.00	6.64	1.81	1.21	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	52.90	15.77	0.00	6.10	3.56	0.51	1.02	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	51.85	13.96	0.00	5.58	0.40	1.20	1.60	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	50.32	12.33	0.00	3.45	0.49	0.99	0.99	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	66.10	21.25	0.00	1.18	1.18	2.36	3.54	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	58.34	7.58	0.00	2.92	2.33	2.33	1.17	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	57.49	13.17	0.00	4.39	0.88	1.76	1.32	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	57.64	11.02	0.00	0.85	1.70	3.39	1.70	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	41.78	8.36	0.00	0.60	3.58	1.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	26.20	8.25	0.00	3.40	2.91	1.46	0.97	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	23.97	57.07	0.00	1.14	2.28	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	30.35	59.88	0.00	7.07	3.74	4.16	1.25	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	28.11	43.85	0.00	2.25	3.37	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	7.93	7.61	0.00	0.63	0.63	0.63	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.01	4.60	0.00	0.00	0.42	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	6.96	9.28	0.00	0.81	0.81	0.23	0.58	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	9.12	12.83	0.00	0.34	0.17	0.00	0.17	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	5.01	11.60	0.00	0.91	1.37	0.23	0.23	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	7.54	10.71	0.00	0.66	0.66	0.66	0.44	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	7.74	14.61	0.00	0.86	1.07	0.43	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	6.89	10.98	0.00	1.72	1.29	0.22	0.22	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	6.73	10.46	0.00	0.75	0.75	0.12	0.37	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	4.97	8.23	0.00	0.00	0.69	0.17	0.51	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	2.88	9.29	0.00	0.32	0.64	0.00	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	48.69	80.59	0.00	9.51	3.36	1.68	2.24	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	67.52	36.35	0.00	3.90	3.46	1.73	2.60	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	34.37	31.73	0.00	7.93	0.00	2.64	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	42.33	19.75	0.00	2.12	1.06	0.71	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	37.05	21.80	0.00	4.36	0.00	0.00	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	22.55	7.52	0.00	0.70	1.57	0.17	0.00	0.52
Hepatocyte, donor1	11523-119I2	7.26	8.47	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	23.70	57.10	0.00	8.62	0.00	2.15	3.23	0.00
Hepatocyte, donor3	11684-122I1	9.20	14.11	0.00	0.61	0.00	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	14.36	2.61	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	22.90	6.64	0.00	0.87	0.35	0.87	0.17	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	34.85	24.97	0.00	1.78	2.47	1.23	0.41	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	6.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	6.68	0.00	0.00	0.00	0.00	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	0.00	0.00	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	1.62	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	1.26	0.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	4.64	1.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	4.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	1.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	2.44	0.81	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.10	0.00	0.00	0.42	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	1.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	3.69	0.92	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.47	0.94	0.00	0.00	0.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	1.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	4.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	1.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	1.82	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	1.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.93	0.93	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	4.87	0.00	0.00	0.00	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	4.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	3.49	0.00	0.00	0.00	0.00	0.00	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2.13	1.07	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	0.92	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	15.34	22.85	0.00	3.59	1.39	0.98	0.73	0.65
Keratinocyte - epidermal, donor2	11349-117G8	8.20	8.78	0.00	0.59	1.76	0.00	0.00	1.17
Keratinocyte - epidermal, donor3	11421-118F8	10.70	11.07	0.28	0.85	0.66	0.66	0.09	0.47
Keratinocyte - oral, donor1	11251-116E9	24.18	11.35	0.00	2.27	0.91	0.79	0.45	0.68
Keratocytes, donor1	11527-119I6	38.85	23.04	0.00	2.06	3.09	0.34	1.38	0.69
Keratocytes, donor2	11607-120I5	25.78	10.55	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	24.90	15.81	0.00	1.78	2.57	0.20	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	158.25	147.26	0.00	2.20	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	38.83	25.89	0.00	2.16	2.16	0.00	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	45.21	27.33	0.00	0.58	3.34	0.23	0.69	1.04
Lens Epithelial Cells, donor3	11690-122I7	24.12	13.02	0.00	1.01	1.72	0.81	0.20	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	32.37	23.72	0.00	3.32	1.42	0.59	0.71	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	23.72	11.16	0.00	1.67	0.56	0.28	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	34.16	24.40	0.00	4.88	1.57	1.73	1.10	1.10
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	15.59	7.53	0.00	2.15	0.00	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	20.80	17.65	0.00	0.95	1.26	0.63	0.63	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	29.33	21.02	0.00	3.67	1.19	1.19	0.97	0.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	22.98	14.77	0.00	0.82	1.64	0.00	0.41	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	27.56	18.20	0.00	2.53	1.01	1.26	0.00	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	28.85	24.77	0.00	4.93	0.84	1.13	1.41	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	17.80	8.70	0.00	0.79	0.40	0.00	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	24.82	18.42	0.00	2.13	0.78	0.78	0.58	1.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	32.77	22.22	0.00	3.52	1.85	0.74	0.93	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	21.25	12.89	0.00	2.44	1.74	1.39	0.70	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	27.43	19.56	0.00	3.34	0.72	0.72	0.00	1.91
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	28.02	20.74	0.00	3.16	1.92	0.82	0.41	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	21.56	14.78	0.00	3.08	1.54	0.92	1.23	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	20.26	14.65	0.00	1.56	1.25	1.25	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	35.87	27.08	0.00	3.66	2.20	0.91	0.73	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	19.42	12.84	0.00	3.29	0.66	0.00	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	23.43	15.82	0.00	4.39	0.88	0.59	0.88	1.17
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	34.60	16.93	0.00	3.98	1.74	1.00	1.24	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	18.91	13.09	0.00	0.97	1.45	0.00	0.48	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	24.78	15.35	0.00	2.96	1.89	0.54	0.54	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	31.79	19.22	0.00	5.75	1.82	1.67	1.21	1.36
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	18.66	16.59	0.00	1.56	1.04	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	25.55	16.54	0.00	2.93	1.26	0.42	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	35.19	23.61	0.00	3.76	1.50	1.50	0.45	1.20
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	18.57	17.88	0.00	2.06	0.69	0.69	0.69	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	22.39	19.00	0.00	2.63	0.38	0.75	0.19	2.07
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	31.81	20.89	0.00	4.24	2.12	2.01	0.53	1.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	17.44	13.57	0.00	2.91	1.94	0.97	0.48	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	19.85	15.88	0.00	1.98	0.66	0.99	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	30.85	23.29	0.00	4.21	2.48	2.11	1.24	1.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	21.47	19.25	0.00	1.85	1.11	0.37	2.59	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	19.77	15.57	0.00	2.22	1.73	0.74	1.24	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	33.00	23.65	0.00	3.71	1.51	1.10	0.69	1.10
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	18.98	18.66	0.00	2.57	1.61	0.32	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	19.78	16.13	0.00	1.52	2.13	2.43	0.61	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	31.49	20.44	0.00	2.52	1.26	1.26	0.28	1.96
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	17.78	17.42	0.00	1.78	1.07	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	15.51	12.60	0.00	0.97	1.94	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	30.81	25.05	0.00	4.98	2.18	1.87	0.62	1.09
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	19.70	15.40	0.00	1.43	0.00	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	26.13	17.97	0.00	1.31	0.65	0.33	0.33	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	26.37	18.13	0.00	2.59	1.18	1.18	0.71	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	30.81	24.50	0.00	2.48	1.73	1.24	0.74	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	24.59	16.14	0.00	2.05	1.28	0.26	0.26	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	28.05	21.48	0.00	2.98	0.60	0.60	0.30	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	2.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	11.51	4.60	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	8.91	2.23	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	5.92	3.81	0.00	0.85	0.42	0.00	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.03	1.41	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	4.67	1.87	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	3.61	1.03	0.00	0.52	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	3.57	0.00	2.38	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	7.92	3.17	0.00	0.45	0.23	0.23	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	6.11	0.87	0.00	0.00	0.29	0.00	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	7.65	2.25	0.00	0.90	0.00	0.00	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	10.70	4.74	0.00	0.95	0.68	0.41	0.14	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	6.16	3.59	0.00	1.54	0.00	0.00	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	6.35	2.47	0.00	0.00	0.35	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	7.33	1.33	0.00	0.00	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	4.58	3.57	0.00	0.00	1.02	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	7.74	6.40	0.00	1.07	0.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	5.67	2.46	0.00	0.38	0.00	0.38	0.38	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	9.82	1.23	0.00	0.61	0.00	0.61	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	8.97	2.45	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	6.25	2.92	0.00	0.42	0.42	0.00	0.42	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	6.73	2.52	0.00	0.84	0.28	0.56	0.56	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	8.24	5.15	0.00	0.00	1.03	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	8.42	3.19	0.00	1.16	0.00	0.87	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	4.48	2.69	0.00	0.30	0.30	0.30	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	9.96	4.98	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	11.31	7.78	0.00	2.83	0.35	1.41	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	5.90	2.21	0.00	0.37	0.37	0.37	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	13.82	5.76	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.44	3.45	0.00	0.38	0.38	0.38	0.00	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	4.53	1.70	0.00	0.57	0.00	1.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	11.49	3.28	0.00	0.00	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.49	5.42	0.00	1.81	0.00	0.00	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	3.59	2.15	0.00	0.00	0.00	0.72	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	1.49	8.22	0.00	0.00	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	8.18	2.97	0.00	1.49	0.37	0.74	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	3.88	3.88	0.00	0.43	0.43	0.86	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.99	3.43	0.00	0.86	0.00	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	7.33	4.00	0.00	1.00	0.67	1.00	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	6.03	2.41	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	7.11	5.69	0.00	0.00	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	10.31	5.50	0.00	0.34	0.34	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	4.83	1.61	0.00	0.54	0.54	1.07	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.10	2.69	0.00	2.02	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	7.78	3.70	0.00	0.37	0.00	0.74	0.37	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	3.49	2.33	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	6.35	5.29	0.00	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	14.01	4.80	0.00	0.00	1.20	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	7.27	2.91	0.00	0.73	0.00	0.73	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	9.20	7.67	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	5.43	2.47	0.00	2.96	0.00	0.00	0.00	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	6.59	0.94	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	10.56	6.03	0.00	1.51	0.50	0.50	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	12.17	7.66	0.00	0.45	0.00	0.90	0.00	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	5.16	3.44	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	10.24	3.12	0.00	0.00	0.00	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	12.12	5.47	0.00	1.17	0.00	1.56	0.78	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	2.64	3.30	0.00	1.32	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	11.42	3.63	0.00	2.59	0.52	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	9.19	4.81	0.00	1.31	0.44	0.88	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	5.03	2.24	0.00	1.12	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	11.92	3.53	0.00	0.00	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	11.19	4.63	0.00	0.00	0.39	0.39	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	9.62	4.56	0.00	1.01	0.00	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	5.77	2.88	0.00	0.48	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.13	5.96	0.00	0.80	0.00	0.40	0.80	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	6.08	1.22	0.00	0.00	0.00	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	4.15	3.46	0.00	0.69	0.69	0.00	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	7.98	6.46	0.00	0.76	0.76	1.52	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	3.61	6.20	0.00	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	5.44	5.44	0.00	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	7.29	7.92	0.00	0.32	0.00	0.32	0.00	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	5.33	1.07	0.00	1.07	0.00	0.00	0.00	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	4.60	2.87	0.00	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	12.86	9.77	0.00	1.03	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	4.24	4.95	0.00	0.00	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	7.94	5.11	0.00	0.57	0.00	1.13	0.00	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.98	8.74	0.00	1.25	0.00	1.25	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	4.70	1.57	0.00	2.35	0.00	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	3.76	2.92	0.00	1.25	0.00	0.84	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	7.43	5.58	0.00	0.00	0.46	0.00	0.00	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	5.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	5.35	2.67	0.00	0.53	0.00	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	7.68	4.45	0.00	1.21	0.00	0.40	0.40	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	8.26	2.75	0.00	0.92	0.00	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	4.45	2.67	0.00	0.00	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	6.84	6.84	0.00	1.14	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	3.83	5.37	0.00	0.00	0.00	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	2.74	2.74	0.00	0.55	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.03	3.12	0.00	0.00	0.00	0.45	0.89	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	9.10	7.02	0.00	0.52	0.26	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	5.30	3.32	0.00	0.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	6.24	0.00	2.08	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	79.09	132.42	0.00	2.96	2.96	0.68	0.91	1.14
Macrophage - monocyte derived, donor2	11313-117C8	41.29	224.06	0.00	2.75	3.12	0.92	1.28	0.37
Macrophage - monocyte derived, donor3	11389-118C3	71.05	195.57	0.00	6.16	5.37	2.10	2.23	2.10
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	5.84	6.90	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	19.33	13.15	0.00	2.06	1.11	1.27	1.43	0.79
Mallassez-derived cells, donor3	11930-125I4	9.17	11.12	0.00	1.11	1.39	0.56	0.28	0.56
Mammary Epithelial Cell, donor1	11273-116H4	3.29	3.79	0.00	0.20	0.80	0.20	0.10	0.00
Mammary Epithelial Cell, donor2	11350-117G9	5.50	6.08	0.00	0.29	0.58	0.58	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	13.22	10.23	0.50	0.25	0.75	0.00	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	8.81	14.91	0.00	3.39	0.68	2.03	1.36	1.36
Mast cell, donor1	11563-120D6	26.28	25.85	0.00	6.06	1.62	0.87	1.95	0.43
Mast cell, donor2	11565-120D8	44.58	18.13	0.00	2.97	1.49	0.30	0.00	0.30
Mast cell, donor3	11566-120D9	36.25	8.78	0.00	1.35	0.90	0.45	0.23	0.00
Mast cell, donor4	11567-120E1	32.27	16.84	0.53	0.71	0.53	0.00	0.53	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	12.97	14.42	0.00	2.88	0.67	0.55	0.78	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	7.59	59.54	0.00	5.84	2.33	2.33	2.33	2.33
Mast cell, expanded, donor5	11939-126A4	22.94	9.75	0.00	1.84	0.57	0.46	1.15	0.80
Mast cell, expanded, donor8	11941-126A6	20.25	15.40	0.00	3.68	1.34	0.33	0.84	0.33
Melanocyte - dark, donor1	11502-119F8	34.43	28.75	0.00	2.49	1.19	0.70	0.50	0.60
Melanocyte - dark, donor2	11582-120F7	23.19	9.69	0.00	1.38	0.69	0.69	1.38	0.35
Melanocyte - dark, donor3	11663-122F7	89.39	429.43	681.09	19.85	9.27	7.17	5.00	7.61
Melanocyte - light, donor1	11274-116H5	60.41	346.73	206.86	55.71	4.94	5.64	6.11	5.41
Melanocyte - light, donor2	11351-117H1	79.17	387.64	399.24	60.74	10.24	8.87	15.01	10.92
Melanocyte - light, donor3	11423-118G1	43.36	116.21	98.86	8.67	4.34	0.87	2.60	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	66.33	160.67	42.48	14.16	5.21	3.33	3.23	2.81
Melanocyte, donor2 (MC+2)	12739-135I3	9.68	21.52	14.79	1.08	0.54	0.54	1.88	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	62.41	169.82	90.53	28.12	4.55	3.75	6.43	5.09
Meningeal Cells, donor1	11493-119E8	41.31	35.61	0.00	2.11	3.35	0.50	0.37	0.87
Meningeal Cells, donor2	11573-120E7	31.25	19.81	0.00	2.20	3.52	0.88	0.44	0.00
Meningeal Cells, donor3	11654-122E7	32.36	23.64	0.00	1.79	2.20	0.90	0.82	0.90
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	22.81	9.70	0.00	0.29	1.14	0.29	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	15.70	19.12	0.00	0.91	1.41	0.20	0.20	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	35.48	21.03	0.00	0.00	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	7.85	0.00	0.00	2.62	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	17.22	7.18	0.00	0.00	1.44	0.72	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	22.66	32.82	0.00	2.75	1.91	0.00	1.06	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	22.62	21.11	0.00	3.52	2.51	1.01	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	31.64	15.82	0.00	0.88	1.76	0.66	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	24.11	14.61	0.00	0.73	0.00	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	33.76	16.98	0.00	1.02	1.02	0.41	0.20	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	11.22	8.86	0.00	0.55	0.42	0.69	0.28	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	29.37	17.84	0.00	1.49	2.23	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	23.55	10.66	0.00	0.66	0.39	0.26	0.66	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	23.74	14.84	0.00	0.89	0.89	0.59	1.19	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	21.02	7.01	0.00	0.00	0.00	4.67	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	35.86	20.49	0.00	0.64	0.00	0.64	0.64	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	13.11	4.61	0.00	1.06	0.71	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	18.76	7.19	0.00	0.31	0.63	0.00	0.00	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	19.59	7.98	0.00	0.73	1.45	0.73	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	20.15	14.32	0.00	1.06	1.06	0.27	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	12.01	15.01	0.00	1.00	0.50	0.00	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	24.21	20.45	0.00	2.10	1.30	0.22	0.51	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	98.57	409.15	0.00	8.10	6.75	1.35	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	64.77	198.74	0.00	3.20	6.65	1.48	1.97	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	42.99	173.14	0.00	4.12	5.89	3.83	1.77	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	114.08	373.36	0.00	0.00	3.46	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	58.27	146.29	0.00	3.10	3.10	1.55	1.86	1.86
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	23.65	132.13	0.00	2.70	3.73	1.87	1.45	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	71.80	284.87	0.00	6.95	6.95	2.32	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	52.81	176.68	0.00	5.51	4.25	2.25	2.50	1.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	34.91	156.40	0.00	2.79	2.79	0.93	1.40	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	116.80	467.19	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	41.05	158.10	0.20	3.45	3.66	1.83	1.02	1.42
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	32.47	138.59	0.00	2.38	2.38	1.58	0.40	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	94.07	299.30	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	29.20	109.73	0.00	5.31	0.88	0.88	2.65	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	25.46	139.44	0.38	2.28	0.76	1.52	1.52	2.66
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	52.64	234.23	0.00	2.63	3.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	35.65	126.70	0.00	5.94	3.18	1.06	2.12	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	40.52	157.46	0.00	0.92	7.37	3.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	31.89	126.97	0.00	2.68	2.38	1.79	2.38	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	62.04	212.94	0.00	5.03	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	712.94	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	33.62	103.37	0.00	3.26	2.51	1.51	1.76	1.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	24.24	115.27	0.00	2.85	3.33	1.66	0.95	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	28.20	127.72	0.00	1.11	0.55	0.55	0.55	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	32.46	109.14	0.00	2.99	2.53	1.38	2.99	1.38
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	22.93	111.69	0.00	1.26	2.94	0.63	0.84	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	26.91	114.76	0.00	0.61	1.83	1.63	0.61	1.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	34.97	100.83	0.00	3.43	3.43	0.86	0.86	1.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	21.56	99.81	0.00	2.22	2.00	2.00	1.33	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	288.92	0.00	0.00	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	23.43	82.79	0.00	2.41	0.88	0.66	0.88	1.31
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	21.80	124.20	0.00	3.04	1.52	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	38.11	130.90	0.00	3.31	1.66	1.66	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	29.08	86.43	0.00	1.36	0.54	1.90	0.54	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	21.47	95.87	0.00	0.59	2.65	1.18	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	22.90	126.48	0.00	8.72	1.09	3.27	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	16.82	80.73	0.00	0.96	1.92	0.00	0.48	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	20.41	92.45	0.00	1.20	2.80	2.00	1.60	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	32.91	134.38	0.00	1.37	4.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	17.02	69.58	0.00	1.50	2.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	26.50	122.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	9.63	65.25	0.00	1.75	1.75	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	38.63	192.04	0.00	1.10	2.21	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	37.78	109.51	0.00	0.64	2.56	1.28	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	12.64	66.69	0.00	1.49	1.24	0.99	1.74	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	29.92	117.61	0.00	1.39	2.78	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	53.04	150.27	0.00	0.00	6.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	24.62	69.74	0.00	2.74	2.05	1.03	1.71	1.71
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	26.26	113.34	0.00	2.19	1.31	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	33.73	105.11	0.00	2.13	2.84	0.36	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	22.72	62.28	0.00	1.96	0.84	0.28	0.28	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	18.29	96.01	0.00	0.83	2.49	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	27.97	88.58	0.00	1.75	4.08	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	15.38	58.82	0.00	2.11	3.02	1.81	0.30	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	16.28	106.85	0.00	1.25	2.09	1.25	0.42	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	158.81	0.00	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	22.17	46.18	0.00	0.92	0.00	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	26.18	117.24	0.00	5.12	5.12	3.41	1.14	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	26.81	60.11	0.00	0.55	1.11	1.24	0.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	19.18	59.86	0.00	1.81	2.33	1.55	1.30	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	34.75	104.24	0.00	1.29	2.14	1.29	2.14	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	40.65	94.01	0.00	0.00	1.91	3.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	17.08	37.63	0.00	0.27	1.60	0.53	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	39.21	119.73	0.00	0.90	2.69	0.90	0.60	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	30.09	57.49	0.00	0.57	2.54	0.57	0.00	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	15.29	54.15	0.00	0.96	1.27	0.64	0.96	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	29.63	112.11	0.00	0.88	3.54	1.11	0.88	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	41.33	61.81	0.00	1.14	1.52	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	21.59	49.43	0.00	0.85	1.99	1.14	0.57	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	25.32	120.20	0.00	3.93	3.69	1.47	0.98	1.23
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	54.74	102.31	0.00	2.61	3.91	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	29.40	51.75	0.00	0.88	2.94	0.59	1.76	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	31.72	108.70	0.00	2.88	1.73	1.73	1.44	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	35.86	98.09	0.00	1.24	2.89	2.47	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	39.61	71.47	0.00	0.89	1.79	2.38	0.00	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	41.44	79.10	0.00	3.77	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	44.56	98.02	0.00	0.00	1.78	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	105.80	207.99	0.00	11.83	4.60	4.93	3.61	3.61
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	55.75	143.07	0.00	9.47	3.16	3.16	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	64.64	165.27	0.00	1.19	1.98	1.98	0.99	1.58
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	35.39	143.42	0.00	5.59	5.59	1.86	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	86.37	219.68	0.00	10.51	5.63	3.00	3.00	3.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	53.27	155.54	0.00	5.86	4.00	0.53	1.86	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	44.11	78.94	0.00	1.47	1.81	1.02	0.68	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	65.57	182.71	0.74	8.10	5.16	3.68	4.42	2.95
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	100.03	194.94	0.00	6.60	4.76	5.13	4.03	5.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	71.56	154.00	0.00	10.89	3.11	4.67	7.78	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	7.48	4.81	0.00	0.53	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	46.37	85.01	0.00	3.86	3.86	0.00	3.86	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	97.96	216.13	0.00	11.11	5.05	6.06	4.04	4.04
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	9.70	64.09	0.00	1.26	2.11	0.42	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	9.53	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	2.54	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	3.24	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	10.57	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	108.49	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	32.62	0.00	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	76.04	0.00	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	150.59	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	14.00	11.20	0.00	2.15	2.37	0.43	0.43	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	16.72	8.36	0.00	2.61	0.52	0.00	1.57	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.68	17.35	0.00	0.00	1.33	0.00	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.86	18.78	0.00	0.00	2.09	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	20.54	4.37	0.00	1.33	0.38	0.95	0.95	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	35.11	25.53	0.00	1.60	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	11.56	21.08	0.00	0.68	1.36	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	9.19	0.00	0.00	0.00	0.00	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.56	33.90	0.00	1.26	1.67	0.42	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	19.99	18.13	0.00	0.93	2.32	0.23	0.46	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	20.81	30.27	0.00	1.62	2.97	0.27	0.81	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	21.02	21.02	0.00	0.00	1.05	0.00	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	8.44	21.84	0.00	1.49	1.49	0.50	1.49	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.37	9.47	0.00	1.08	2.17	0.81	0.54	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.24	24.94	0.00	0.91	2.04	1.13	0.45	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	28.25	38.05	0.00	0.65	3.10	0.49	0.65	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	24.79	28.98	0.00	1.46	2.37	0.91	0.91	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	17.50	28.11	0.00	0.53	2.65	1.06	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	10.81	32.42	0.00	0.60	1.80	1.20	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	9.52	2.95	0.00	2.30	0.98	1.97	0.66	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	16.26	28.30	0.00	0.81	2.28	0.49	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	26.81	48.15	0.00	0.71	2.12	1.41	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	17.58	43.60	0.00	0.70	4.92	1.41	2.11	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	12.87	30.34	0.00	1.84	0.92	0.00	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	27.96	67.80	0.00	1.93	2.57	0.64	0.64	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	8.62	6.55	0.00	3.45	0.34	2.07	1.38	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	7.59	7.59	0.00	0.00	2.53	2.53	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	26.51	40.55	0.00	0.45	3.12	0.22	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	25.40	42.34	0.00	1.27	2.12	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	12.34	10.92	0.00	0.47	1.19	0.95	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	18.89	51.51	0.00	3.00	3.00	1.29	0.43	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	19.66	40.99	0.00	1.33	3.33	1.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	25.70	38.77	0.00	0.45	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.90	33.73	0.00	0.40	2.38	0.40	0.40	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	9.29	41.79	0.00	0.93	0.93	0.00	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	22.70	17.41	0.00	2.65	0.38	0.38	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	12.38	33.24	0.00	1.30	2.61	0.65	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.87	37.91	0.00	0.00	0.87	0.44	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.00	29.85	0.00	2.26	3.17	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	6.17	30.87	0.00	2.65	1.76	0.88	0.88	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	10.64	43.88	0.00	1.99	1.33	1.33	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	13.89	47.62	0.00	0.50	1.98	1.98	1.49	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.87	32.54	0.00	0.00	0.00	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	28.43	27.52	0.00	2.12	3.02	0.91	0.60	1.51
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	16.80	20.33	0.00	0.88	1.77	0.00	0.66	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	10.16	25.75	0.00	2.03	1.36	0.68	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	5.11	0.00	15.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	17.68	40.24	0.00	1.83	1.83	0.61	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	14.48	24.23	0.00	0.00	1.57	0.94	0.94	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	18.46	29.05	0.00	1.21	2.12	1.21	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	10.28	16.61	0.00	2.37	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	7.94	1.13	0.00	4.53	0.00	3.40	4.53	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	7.21	5.96	0.00	0.12	0.37	0.25	0.12	0.25
Myoblast, donor2	11322-117D8	20.33	21.67	0.00	1.53	0.96	1.53	0.58	0.77
Myoblast, donor3	11398-118D3	13.28	9.59	0.00	0.00	0.00	0.00	0.00	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	11.67	4.23	0.00	1.02	0.00	0.00	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	9.53	4.00	0.00	0.92	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	8.14	1.51	0.00	0.00	0.00	0.30	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	7.36	3.87	0.00	0.00	0.00	0.00	0.00	0.18
Neural stem cells, donor1	11275-116H6	86.38	108.52	0.00	23.59	12.34	2.90	6.17	2.54
Neural stem cells, donor2	11352-117H2	119.39	125.17	0.00	9.63	13.48	1.93	9.63	1.93
Neurons, donor1	11494-119E9	67.14	40.96	0.00	4.55	0.00	3.41	0.00	2.28
Neurons, donor2	11574-120E8	64.29	34.57	0.00	4.18	2.42	1.98	1.10	0.66
Neurons, donor3	11655-122E8	69.88	44.40	0.00	3.29	1.64	0.82	0.82	2.47
Neutrophils, donor1	11233-116C9	21.34	5.57	0.00	0.93	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	31.89	5.80	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	33.60	9.77	0.00	1.22	0.61	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	26.24	16.50	0.00	1.54	1.54	0.71	0.24	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	29.63	17.91	0.00	1.63	0.98	2.28	0.33	1.95
Nucleus Pulposus Cell, donor3	11462-119B4	11.23	11.43	0.00	1.20	1.00	0.40	0.20	0.60
Olfactory epithelial cells, donor1	11933-125I7	21.06	18.45	0.00	1.24	2.89	0.83	0.69	1.24
Olfactory epithelial cells, donor2	11934-125I8	21.71	26.92	0.00	1.74	2.03	2.32	1.59	1.88
Olfactory epithelial cells, donor3	11935-125I9	23.61	39.61	0.00	1.48	1.25	0.91	0.91	1.02
Olfactory epithelial cells, donor4	11936-126A1	21.23	29.32	0.00	1.17	3.31	0.97	0.19	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	30.69	9.63	0.00	1.20	1.81	0.60	0.00	1.81
Osteoblast - differentiated, donor1	11276-116H7	14.46	18.08	0.00	1.91	1.70	0.00	0.43	0.21
Osteoblast - differentiated, donor2	11353-117H3	4.57	8.00	0.00	1.14	0.00	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.03	13.03	0.00	0.00	0.00	0.62	0.62	0.62
Osteoblast, donor1	11277-116H8	64.49	43.39	0.00	2.35	4.50	0.00	0.00	0.39
Osteoblast, donor2	11354-117H4	44.25	23.88	0.00	2.11	0.00	1.40	0.70	2.81
Osteoblast, donor3	11426-118G4	48.88	29.15	0.00	1.24	1.42	0.71	0.36	0.36
Pancreatic stromal cells, donor1	11249-116E7	14.49	13.39	0.00	3.12	0.42	0.84	0.67	1.01
Pericytes, donor1	11491-119E6	27.37	22.14	0.00	3.12	2.45	0.33	0.67	0.45
Pericytes, donor2	11571-120E5	24.90	21.50	0.00	2.72	2.94	0.91	0.23	1.81
Pericytes, donor3	11652-122E5	24.01	10.78	0.00	1.83	1.63	0.00	0.61	0.41
Perineurial Cells, donor1	11499-119F5	21.47	8.70	0.00	0.68	1.13	0.11	0.23	0.34
Perineurial Cells, donor2	11579-120F4	25.30	13.89	0.00	1.38	1.38	0.18	0.64	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	26.14	18.49	0.00	0.96	2.55	0.96	0.32	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	27.67	25.96	0.00	1.96	0.73	0.73	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	23.81	19.67	0.00	1.16	1.29	0.00	0.26	0.39
Placental Epithelial Cells, donor1	11278-116H9	11.48	2.87	0.00	0.48	0.24	0.00	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	33.27	13.31	0.00	2.22	1.11	2.22	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	43.78	8.25	0.00	3.14	0.59	0.39	0.39	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.01	12.34	0.00	1.58	0.95	0.32	0.95	0.32
Preadipocyte - breast, donor1	11467-119B9	12.01	12.38	0.00	0.94	0.56	0.38	0.56	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	8.48	7.18	0.00	0.26	0.78	0.13	0.00	0.26
Preadipocyte - breast, donor2	11328-117E5	15.31	18.01	0.00	2.70	1.13	1.13	0.68	0.68
Preadipocyte - omental, donor1	11468-119C1	14.49	19.07	0.00	1.60	1.28	0.32	1.07	0.64
Preadipocyte - omental, donor2	11329-117E6	14.84	15.71	0.00	1.31	1.75	0.00	1.31	0.00
Preadipocyte - omental, donor3	11403-118D8	24.07	21.77	0.00	2.15	2.01	0.57	1.29	0.14
Preadipocyte - perirenal, donor1	11469-119C2	12.80	24.61	0.00	1.97	1.97	0.98	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	24.57	23.34	0.00	1.23	0.31	0.61	0.00	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	26.74	24.61	0.00	2.48	0.71	1.42	1.06	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	25.71	25.54	0.00	3.58	1.53	0.51	0.68	0.68
Preadipocyte - visceral, donor1	11280-116I2	23.38	25.06	0.00	3.17	1.30	0.84	0.75	0.65
Preadipocyte - visceral, donor2	11357-117H7	17.49	20.71	0.00	8.28	2.76	1.38	0.92	0.92
Preadipocyte - visceral, donor3	11429-118G7	13.37	17.45	0.00	0.94	1.36	0.10	0.94	1.46
Prostate Epithelial Cells (polarized), donor1	11253-116F2	25.34	8.45	0.00	5.13	0.60	0.91	1.36	0.15
Prostate Epithelial Cells, donor2	11331-117E8	20.85	26.95	0.00	6.23	1.22	2.17	1.62	0.81
Prostate Epithelial Cells, donor3	11404-118D9	6.74	6.61	0.00	1.47	0.49	0.06	0.31	0.12
Prostate Stromal Cells, donor1	11254-116F3	14.58	10.59	0.00	2.39	0.68	0.34	0.68	0.46
Prostate Stromal Cells, donor2	11332-117E9	23.31	26.89	0.00	3.77	1.26	1.79	0.54	1.08
Prostate Stromal Cells, donor3	11405-118E1	24.30	18.77	0.00	3.34	2.09	1.25	0.52	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	54.38	26.64	0.00	1.46	1.82	0.00	0.36	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	29.80	12.13	0.00	1.87	0.35	0.69	0.55	0.69
Renal Epithelial Cells, donor1	11517-119H5	89.27	53.77	0.00	1.52	6.59	0.51	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	56.19	44.81	0.00	2.13	3.56	1.42	1.42	2.13
Renal Epithelial Cells, donor3	11678-122H4	53.89	22.97	0.00	2.96	1.59	1.48	0.64	1.16
Renal Glomerular Endothelial Cells, donor1	11514-119H2	42.89	57.19	0.00	4.09	4.77	3.40	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	33.02	39.76	0.00	4.04	3.37	1.48	0.54	1.21
Renal Glomerular Endothelial Cells, donor3	11675-122H1	42.18	23.31	0.00	1.55	2.22	0.89	1.33	1.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	74.53	55.90	0.00	10.65	3.33	2.66	3.99	3.99
Renal Mesangial Cells, donor1	11518-119H6	68.89	52.82	0.00	4.84	4.84	1.10	1.32	2.64
Renal Mesangial Cells, donor2	11598-120H5	82.13	38.87	0.00	5.02	6.27	2.51	1.88	0.63
Renal Mesangial Cells, donor3	11679-122H5	70.46	58.53	0.00	4.72	5.27	1.11	2.22	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	19.33	17.18	0.00	0.54	1.88	0.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.54	6.33	0.00	0.42	2.53	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	61.33	38.18	0.00	3.66	3.86	1.93	0.77	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	45.37	32.93	6.48	1.56	2.07	1.81	0.78	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	55.71	23.59	0.00	2.27	2.56	0.28	1.14	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	62.78	22.64	0.00	4.12	1.03	3.09	1.03	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	13.55	13.05	0.00	2.76	1.51	0.75	0.50	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	9.22	13.36	0.00	1.47	0.00	0.27	0.27	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	16.08	8.93	0.00	0.00	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	3.85	2.20	0.00	3.85	1.10	0.00	2.75	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	8.12	0.58	0.00	0.58	0.00	1.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	9.88	6.37	0.00	0.26	0.78	0.39	0.39	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	16.29	10.33	0.10	0.50	1.19	0.70	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	19.18	12.38	0.11	0.67	2.12	0.22	0.45	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	14.51	6.70	0.00	1.49	0.87	0.37	0.62	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	16.20	11.19	0.00	1.75	1.98	0.70	0.82	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	17.80	10.17	0.00	1.16	1.85	0.23	0.46	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	13.69	6.30	0.14	0.96	0.82	0.68	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	16.49	8.02	0.00	1.06	1.21	0.61	0.76	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	21.68	15.23	0.00	0.36	0.90	0.00	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	14.20	8.32	0.00	1.29	1.43	0.86	0.86	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	18.89	8.91	0.11	1.18	1.50	0.43	0.21	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	18.59	11.95	0.00	1.11	0.22	0.66	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	12.04	7.07	0.00	0.19	0.96	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	16.30	7.92	0.09	0.84	1.30	0.56	0.28	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	19.35	11.27	0.00	0.94	1.88	1.50	0.75	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	12.34	5.84	0.00	0.66	0.66	0.13	0.13	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	20.54	9.15	0.00	1.46	1.17	0.78	0.78	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	18.71	13.75	0.00	1.15	1.34	0.57	0.57	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	12.07	7.16	0.00	0.85	0.75	0.53	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	11.49	8.41	0.28	1.68	0.56	1.12	1.12	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	20.00	9.40	0.00	1.54	0.85	0.51	0.85	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	10.94	6.93	0.00	0.91	0.73	0.18	0.73	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	18.76	11.77	0.25	0.86	1.47	1.23	0.37	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	20.28	13.03	0.13	1.07	1.21	0.81	0.13	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	9.20	7.55	0.24	1.18	0.94	0.24	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	17.26	8.13	0.20	0.99	1.39	0.79	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	19.88	12.63	0.00	1.64	1.17	0.23	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	9.12	7.26	0.21	0.83	1.24	0.21	0.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	11.72	8.63	0.00	1.77	0.66	1.11	0.66	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	20.89	12.53	0.00	1.67	1.46	0.63	0.63	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	12.11	7.00	0.13	0.94	0.67	0.40	0.13	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	15.33	8.86	0.17	0.34	1.36	0.34	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	20.82	13.50	0.00	0.96	1.35	0.19	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	12.38	7.57	0.34	1.72	1.20	0.34	0.69	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	15.64	9.74	0.14	0.69	0.41	0.55	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	14.28	9.52	0.00	0.99	0.49	0.66	0.16	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	13.46	8.18	0.00	1.19	0.68	0.34	0.34	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	23.53	11.10	0.00	1.78	1.48	1.33	0.00	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	20.26	7.46	0.00	0.00	1.33	1.07	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	11.75	7.05	0.00	1.24	0.55	0.28	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	20.24	6.67	0.00	2.14	0.48	0.48	0.00	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	19.55	14.31	0.00	1.61	1.01	1.21	0.60	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	11.02	8.38	0.19	2.54	1.04	0.19	0.38	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	11.88	11.88	0.35	2.79	1.40	0.70	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	13.30	8.76	0.00	0.30	1.51	0.60	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	10.77	9.18	0.12	3.79	0.98	0.86	0.37	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	27.22	19.36	0.73	0.58	2.18	0.29	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	15.21	11.56	0.00	2.43	0.61	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	12.36	4.82	0.00	1.51	0.00	0.00	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	30.99	18.32	0.23	8.82	2.71	2.26	1.13	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	27.56	13.78	0.00	4.49	1.50	1.20	1.50	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	14.52	11.69	0.12	10.51	1.42	0.71	0.94	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	18.78	16.65	0.43	3.42	2.13	1.07	0.85	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	20.43	12.62	0.00	0.00	1.80	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	42.32	22.57	0.00	3.57	2.26	0.94	0.38	0.94
Schwann Cells, donor2	11578-120F3	37.43	13.61	0.00	3.40	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	48.20	28.26	0.00	2.41	4.16	1.53	0.44	0.44
Sebocyte, donor1	11220-116B5	43.82	35.61	0.00	6.03	2.74	0.00	1.10	0.00
Sebocyte, donor2	11301-117B5	19.30	20.22	0.00	10.11	1.38	1.38	1.84	0.46
Sebocyte, donor3	11378-118B1	30.50	28.03	0.00	3.71	0.62	1.03	1.03	0.41
Sertoli Cells, donor1	11255-116F4	29.82	21.54	0.00	1.66	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	5.65	5.65	0.00	2.82	0.00	0.00	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	31.23	22.87	0.00	5.89	2.90	0.62	0.97	0.53
Skeletal Muscle Cells, donor2	11358-117H8	20.96	15.18	0.00	0.72	2.17	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	52.67	41.80	0.00	3.34	5.02	1.67	1.67	2.51
Skeletal Muscle Cells, donor4	11451-119A2	12.57	7.85	0.00	0.94	0.16	0.00	0.16	0.47
Skeletal Muscle Cells, donor5	11455-119A6	17.54	14.27	0.00	0.30	0.59	0.59	0.45	0.30
Skeletal Muscle Cells, donor6	11459-119B1	23.70	11.70	0.00	0.62	0.62	0.62	0.46	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	26.84	11.72	0.00	2.65	0.88	0.38	1.01	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	27.11	12.70	0.00	2.43	2.14	0.29	0.71	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	32.94	19.84	0.00	1.69	0.99	0.30	0.50	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	29.32	29.74	0.08	2.70	2.70	0.93	0.84	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	31.12	20.99	0.00	1.45	0.72	0.72	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	34.67	55.45	0.00	3.44	3.58	1.38	1.24	1.65
Skin - palm, donor1	10286-104F7	5.37	8.06	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.23	10.96	0.00	1.15	0.43	0.72	0.43	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	16.36	17.99	0.00	0.00	0.82	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.97	8.57	0.00	1.17	0.65	0.26	0.39	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	9.04	6.26	0.00	1.25	0.42	0.14	0.14	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	14.63	7.45	0.00	0.70	0.14	0.42	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	29.39	23.05	0.00	0.42	0.63	0.21	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	10.34	9.97	0.00	0.97	0.37	0.52	0.52	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	10.49	9.57	0.00	2.78	0.00	0.31	0.00	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	18.45	23.79	0.00	4.22	1.33	0.44	0.67	1.33
Smooth Muscle Cells - Aortic, donor0	11210-116A4	27.04	27.04	0.00	0.59	1.76	0.59	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	55.25	50.17	0.00	1.99	4.42	1.10	0.44	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	23.23	28.75	0.00	1.18	0.39	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	34.77	35.54	0.00	0.77	2.32	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	13.01	7.01	0.00	2.00	0.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	42.05	51.37	0.00	3.86	2.40	0.40	0.13	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	13.52	8.20	0.00	0.44	0.66	0.89	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	6.66	4.10	0.00	0.13	0.13	0.00	0.38	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	21.16	14.98	0.00	0.00	1.63	0.65	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	30.71	21.26	0.00	0.59	2.66	0.00	0.59	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	20.50	10.11	0.00	0.85	1.00	0.43	0.43	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	32.70	27.49	0.00	1.14	2.77	0.16	0.16	0.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	7.61	6.39	0.00	0.61	1.22	1.52	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	31.82	22.48	0.00	1.26	1.77	0.25	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	30.60	0.00	0.00	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	33.86	25.27	0.00	3.81	1.91	0.95	2.38	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	22.12	10.91	0.00	1.18	1.33	0.15	0.44	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	25.18	14.64	0.00	1.72	0.43	1.08	0.65	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	35.79	19.31	0.00	1.78	1.47	0.52	0.52	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	32.48	34.34	0.00	0.93	1.24	0.93	0.46	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	23.71	35.57	0.00	2.16	1.08	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	22.41	38.25	0.00	1.49	1.79	0.90	0.30	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	52.23	22.19	0.00	2.39	0.68	0.34	0.34	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	20.26	8.64	0.00	1.10	0.55	0.24	0.24	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	14.09	18.62	0.00	6.14	1.71	0.50	3.02	0.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	21.39	35.04	0.00	2.50	2.73	2.05	0.68	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	11.47	31.40	0.00	5.43	0.00	2.42	0.60	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	26.76	14.04	0.00	1.32	1.06	0.00	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	14.91	16.11	0.00	2.13	0.80	0.00	0.80	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	30.80	23.92	0.00	5.01	2.25	1.13	1.75	1.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	7.61	6.85	0.00	0.25	0.76	0.25	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	34.83	47.34	0.00	3.62	2.11	0.45	0.90	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	21.75	40.51	0.00	0.00	2.25	0.75	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	80.12	43.94	0.00	3.88	1.29	1.29	1.29	5.17
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	47.44	66.51	0.00	3.26	2.33	0.47	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	28.27	21.71	0.00	2.02	1.51	1.51	1.51	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	11.60	14.73	0.00	1.57	0.31	0.00	0.94	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	20.35	17.99	0.00	0.59	1.77	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	23.08	13.83	0.00	0.25	0.92	0.17	0.17	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	27.10	16.82	0.47	1.40	0.93	0.47	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	31.95	20.87	0.00	1.73	1.87	0.43	0.43	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	40.79	31.36	0.00	2.29	2.55	1.02	1.53	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	24.07	25.01	0.00	1.69	1.32	0.56	0.19	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	29.77	9.78	0.00	0.84	0.98	0.42	0.14	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	34.10	13.41	0.00	0.92	1.01	0.34	0.34	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	37.62	9.52	0.00	1.43	0.00	0.48	0.00	1.90
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	25.69	16.88	0.00	1.96	1.47	0.98	0.24	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	5.97	20.77	0.00	3.31	1.33	0.00	0.22	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	13.17	6.14	0.00	0.59	0.00	0.88	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	21.77	15.94	0.00	2.53	2.72	0.19	1.17	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	18.25	20.63	0.00	2.91	1.32	0.26	1.32	3.44
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.21	1.49	0.00	4.84	0.00	0.00	3.72	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	10.78	11.86	0.00	0.36	0.72	0.36	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	8.80	12.21	0.00	0.85	0.00	0.00	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	14.57	10.63	0.00	3.15	0.79	0.00	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	10.41	11.94	0.00	2.29	1.27	0.00	2.54	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	13.58	9.98	0.00	4.39	0.80	0.80	0.80	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	13.79	12.96	0.00	1.67	0.42	0.00	1.67	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	20.17	15.13	0.00	0.92	2.29	0.46	0.00	0.92
Synoviocyte, donor1	11291-117A4	10.10	6.90	0.00	1.18	0.67	0.00	0.17	0.34
Synoviocyte, donor2	11368-117I9	9.55	10.73	0.00	1.51	1.34	0.17	0.84	0.34
Synoviocyte, donor3	11440-118H9	5.81	8.04	0.00	0.45	0.45	0.00	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	81.11	40.74	0.00	2.50	4.29	1.43	0.36	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	9.91	0.00	0.00	1.98	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	55.11	27.32	0.00	3.24	2.55	0.93	0.46	1.39
Tracheal Epithelial Cells, donor1	11292-117A5	7.96	6.31	0.00	0.22	1.29	0.14	0.00	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	20.49	17.40	0.00	0.77	1.16	1.16	0.00	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	12.60	11.45	0.00	0.57	2.29	0.00	1.15	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	9.35	12.92	0.00	1.60	0.37	0.12	0.49	0.00
Urethra, donor2	10319-105A4	8.99	7.19	0.00	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	28.43	21.25	0.00	3.45	0.80	0.80	0.80	1.06
Urothelial Cells, donor2	11600-120H7	19.63	14.02	0.00	0.40	0.00	0.40	0.40	0.80
Urothelial Cells, donor3	11681-122H7	27.50	15.59	0.00	1.60	0.23	0.69	0.00	0.46
Urothelial cells, donor0	11216-116B1	37.22	8.25	0.00	2.01	0.22	0.45	0.45	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	16.91	11.57	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	17.16	17.16	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	15.74	11.64	0.00	0.00	0.00	2.74	0.00	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	12.74	8.61	0.00	0.34	0.00	0.34	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	15.11	8.13	0.00	0.00	1.74	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	9.37	14.58	0.00	1.04	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	12.85	13.77	0.00	1.84	0.00	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	17.35	14.61	0.00	0.00	0.00	0.91	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	18.26	17.15	0.00	1.23	1.11	0.25	0.12	0.25
Wilms' tumor cell line:HFWT	10597-108E3	18.48	15.84	0.00	0.88	6.16	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	32.12	11.73	0.00	1.68	0.28	0.28	0.28	0.84
achilles tendon, donor2	10292-104G4	16.53	10.33	0.00	0.00	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	33.91	21.16	0.00	1.27	0.51	0.51	0.51	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	17.18	6.50	0.00	0.00	0.23	0.46	0.93	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	10.33	1.07	0.00	0.12	0.12	0.00	0.12	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	17.69	0.82	0.00	0.27	0.27	0.27	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	14.62	8.43	0.00	0.56	2.53	0.84	0.28	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	12.48	2.54	0.00	0.42	0.00	0.21	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	17.15	13.34	0.00	0.82	0.82	0.54	0.54	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	5.29	0.88	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	28.99	5.72	0.00	1.23	0.41	0.00	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	76.49	73.00	0.00	0.78	3.88	1.55	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	1.66	0.18	0.00	0.00	0.00	0.18	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	3.90	7.80	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	33.70	27.19	0.00	2.09	0.93	0.70	0.23	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	28.74	11.13	0.00	2.33	0.52	0.52	0.78	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	22.80	3.21	0.00	0.58	0.29	0.29	0.88	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	20.45	8.83	0.00	0.00	1.39	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	2.88	0.41	0.00	0.00	0.00	0.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	22.71	14.73	0.00	0.31	1.53	1.84	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	26.88	12.80	0.00	0.43	1.71	0.43	0.43	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	22.14	17.89	0.00	0.91	0.91	0.00	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	24.31	18.78	0.00	1.44	0.96	0.24	0.72	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	14.48	7.13	0.00	0.67	0.45	0.89	0.67	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	15.68	15.01	0.00	1.33	1.67	0.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	9.29	1.86	0.00	0.00	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	9.42	3.77	0.00	0.00	0.00	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	27.91	1.74	0.00	0.87	0.00	0.87	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	35.61	15.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	10.83	5.65	0.00	0.24	0.47	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	14.58	38.00	0.00	5.12	1.09	0.31	1.71	0.78
adipose, donor1	10184-103D4	22.87	4.69	0.00	5.28	2.93	0.00	2.35	1.17
adipose, donor2	10185-103D5	59.61	29.20	0.00	5.27	8.52	0.41	0.81	0.41
adipose, donor3	10186-103D6	65.89	35.13	0.00	2.72	4.08	1.36	0.54	0.82
adipose, donor4	10187-103D7	104.88	52.01	0.00	1.73	0.87	2.60	2.60	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	14.36	9.00	0.00	0.00	0.32	0.16	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	7.28	14.55	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	2.13	0.67	0.67	0.13	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	13.22	7.86	0.00	1.43	0.36	0.36	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	4.87	3.48	0.00	0.00	0.70	0.23	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	22.31	13.86	0.00	0.00	0.34	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	2.65	0.88	0.00	0.00	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	20.16	30.83	0.00	1.19	3.56	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	21.29	31.23	0.00	2.84	1.82	1.42	1.82	0.61
amygdala, newborn, donor10223	10360-105E9	15.49	29.05	0.00	1.94	4.52	0.97	0.97	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	14.26	24.96	0.00	1.53	0.64	0.00	0.25	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	24.05	16.55	0.00	1.54	0.88	0.44	0.22	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	33.07	4.01	0.00	0.33	0.67	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	13.73	15.89	0.00	0.78	1.18	0.59	0.00	0.00
appendix, adult	10189-103D9	10.48	16.69	0.00	2.33	0.78	0.00	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	15.48	2.06	0.00	0.00	0.00	0.34	1.03	0.34
artery, adult	10190-103E1	4.08	5.43	0.00	1.36	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	23.61	18.40	0.14	1.59	3.77	0.29	0.14	0.43
b cell line:RPMI1788	10427-106D4	13.98	7.88	0.00	1.34	0.74	0.15	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	18.87	13.87	0.00	0.83	0.83	0.83	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	13.79	8.73	0.00	0.20	0.89	0.00	0.10	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	3.01	3.01	0.00	0.17	0.17	0.17	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	25.72	20.13	0.00	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	7.17	5.21	0.00	0.54	0.33	0.11	0.00	0.00
blood, adult, pool1	10053-101G8	17.72	8.86	0.00	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	15.41	11.13	0.00	0.00	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	12.82	31.72	0.00	2.70	0.00	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	23.58	53.30	0.00	3.08	4.10	0.00	0.00	2.05
brain, adult, pool1	10012-101C3	10.24	15.59	0.00	2.90	1.56	0.56	0.56	0.56
brain, fetal, pool1	10085-102B4	96.17	109.53	0.00	0.00	5.34	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	11.56	1.98	0.00	0.33	0.00	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	29.33	18.97	0.00	0.75	0.75	0.50	0.37	0.25
breast, adult, donor1	10080-102A8	13.89	12.63	0.00	0.63	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	7.50	10.16	0.00	0.64	1.27	0.00	0.25	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	19.48	5.57	0.00	0.31	0.00	0.62	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	3.68	1.15	0.00	0.69	0.00	0.46	0.23	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	3.15	0.73	0.00	0.00	0.00	0.24	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	42.79	9.40	0.00	0.47	0.94	0.47	0.94	0.94
carcinoid cell line:NCI-H727	10735-110B6	3.06	0.55	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	10.14	1.90	0.00	0.00	0.00	0.00	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	17.04	3.46	0.00	1.60	0.27	1.06	0.27	0.53
caudate nucleus - adult, donor10196	10177-103C6	12.66	18.42	0.00	1.15	0.00	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	10.54	23.43	0.00	1.84	2.01	0.67	0.33	0.33
caudate nucleus, adult, donor10258	10379-105H1	16.05	17.58	0.00	3.06	2.29	0.76	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	13.92	34.06	0.00	1.83	2.20	1.10	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	20.39	67.01	0.00	2.91	2.91	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	35.66	49.11	0.00	4.70	2.78	1.28	1.28	0.21
cerebellum, adult, pool1	10083-102B2	24.84	49.33	0.00	4.48	7.59	1.03	1.03	0.69
cerebellum, newborn, donor10223	10357-105E6	18.27	31.55	0.00	1.66	3.32	1.66	0.00	0.00
cerebral meninges, adult	10188-103D8	10.34	12.35	0.00	1.51	0.76	1.01	0.00	0.50
cerebrospinal fluid, donor2	10294-104G6	6.58	16.08	0.00	0.73	0.73	0.73	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	1.58	1.15	0.00	0.14	0.14	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	2.98	1.16	0.00	0.17	0.33	0.17	0.00	0.33
cervix, adult, pool1	10013-101C4	11.23	7.14	0.00	0.52	0.42	0.21	0.10	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	25.64	34.83	0.00	1.39	2.09	0.28	0.42	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	61.39	20.90	0.00	0.00	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	20.88	7.21	0.00	3.23	1.49	0.25	1.12	0.75
choriocarcinoma cell line:SCH	10785-110H2	2.59	0.49	0.00	0.25	0.25	0.00	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	19.21	8.06	0.00	0.00	2.37	0.00	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	6.27	5.98	0.00	0.00	0.28	0.28	0.57	0.57
chorionic membrane cells, donor2	12239-129G7	41.86	33.61	0.00	3.98	1.39	0.70	1.59	0.60
chorionic membrane cells, donor3	12240-129G8	8.79	3.85	0.00	1.65	0.00	0.55	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	6.06	1.01	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	37.65	18.44	0.00	1.54	2.11	0.38	0.58	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	10.35	3.80	0.00	0.21	0.42	0.21	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	2.04	0.00	0.00	0.20	0.00	0.20	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	2.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	14.07	2.87	0.00	0.52	0.78	0.00	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	24.92	7.09	0.00	0.46	0.46	0.46	0.23	0.46
clear cell carcinoma cell line:TEN	10636-108I6	6.25	5.55	0.00	0.35	0.00	0.17	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	11.90	2.56	0.00	0.00	0.18	0.18	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	15.58	3.42	0.00	0.76	0.76	0.38	0.76	0.00
colon, adult, donor1	10082-102B1	16.66	10.71	0.00	1.19	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	9.28	12.34	0.00	0.35	0.12	0.12	0.59	0.12
colon, fetal, donor1	10070-101I7	12.36	14.21	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	220.01	9.17	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	4.67	16.57	0.00	0.42	0.42	0.00	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	12.98	18.87	0.00	1.66	1.36	0.15	0.91	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	14.38	21.72	0.00	0.56	1.69	0.28	0.56	0.42
corpus callosum, adult, pool1	10042-101F6	14.93	17.47	0.00	1.44	1.44	0.66	0.22	0.22
cruciate ligament, donor2	10295-104G7	9.73	17.83	0.00	0.00	0.00	1.62	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	22.47	16.85	0.00	2.41	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	10.80	13.44	0.00	0.48	1.44	0.00	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	9.41	0.46	0.00	0.92	0.23	0.00	0.00	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	11.54	3.85	0.00	0.51	0.51	0.51	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	9.39	7.22	0.00	0.48	0.72	0.24	0.48	0.48
ductus deferens, adult	10196-103E7	6.98	10.96	0.00	0.00	1.00	0.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	17.28	24.48	0.00	0.00	1.44	0.00	4.32	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	22.07	19.86	0.00	2.94	1.47	0.00	3.68	1.47
dura mater, adult, donor1	10041-101F5	42.86	54.67	0.00	3.14	3.06	0.83	1.32	0.99
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	5.77	5.11	0.00	0.67	0.44	0.22	0.22	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	16.91	9.46	0.00	1.43	1.86	0.14	1.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	25.28	5.55	0.00	0.00	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	13.92	2.42	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	19.45	12.97	0.00	0.00	0.00	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	34.15	10.51	0.00	0.00	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	37.88	47.26	0.00	1.68	2.35	1.01	0.67	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	27.73	9.42	0.00	1.09	1.09	0.36	0.36	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	17.05	20.42	0.00	1.77	0.32	0.80	0.48	0.80
epidermoid carcinoma cell line:A431	10426-106D3	7.56	3.89	0.00	0.22	0.22	0.11	0.33	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	21.34	14.19	0.00	0.88	0.55	0.44	0.33	0.33
epididymis, adult	10197-103E8	10.88	15.91	0.00	1.67	1.05	0.00	1.26	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	7.45	4.97	0.00	0.35	0.71	0.53	0.53	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	3.54	7.08	0.00	0.00	1.18	0.00	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	2.36	1.44	0.00	0.26	0.00	0.13	0.13	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	2.26	1.57	0.00	0.20	0.20	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	3.36	1.68	0.00	0.22	0.11	0.11	0.11	0.22
esophagus, adult, pool1	10015-101C6	4.78	7.22	0.00	0.32	0.11	0.11	0.11	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	50.34	122.48	0.00	4.63	8.02	1.75	1.25	1.25
eye - muscle inferior rectus, donor1	10272-104E2	4.83	4.83	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	14.73	4.21	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	2.98	1.49	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	5.73	8.03	0.00	0.00	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	17.49	20.40	0.00	1.46	0.00	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	19.07	28.47	0.76	2.54	1.27	1.78	0.76	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	20.52	10.00	0.00	1.15	1.67	0.13	0.26	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	6.65	13.53	0.00	0.71	0.95	0.24	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	21.58	32.93	0.00	2.35	3.94	1.13	0.56	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	12.91	5.70	0.00	0.30	0.90	0.30	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	41.70	13.08	0.00	1.55	0.82	0.55	0.27	0.18
gall bladder, adult	10198-103E9	14.49	17.62	0.00	1.93	0.72	0.48	1.45	0.24
gamma delta positive T cells, donor1	11937-126A2	5.91	1.07	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	12.33	6.72	0.00	0.37	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	13.10	5.70	0.00	0.00	0.42	0.21	0.63	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	14.70	19.73	0.00	0.19	1.16	0.39	0.58	0.39
gastric cancer cell line:AZ521	10549-107H9	13.77	4.10	0.00	0.82	0.98	0.49	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	29.29	5.49	1.83	2.75	0.92	0.00	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	10.28	7.31	0.00	0.69	0.46	0.00	0.23	0.00
giant cell carcinoma cell line:LU65	10487-107B1	0.69	0.69	0.00	0.00	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	33.17	10.64	0.00	1.12	2.66	0.14	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	2.24	4.24	0.00	0.00	0.25	0.25	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	38.84	31.45	0.00	1.79	1.79	1.27	0.42	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	55.33	46.91	0.00	1.54	1.26	0.98	1.54	0.56
glioblastoma cell line:T98G	10485-107A8	35.54	15.78	0.00	0.88	1.66	0.55	0.44	0.33
glioma cell line:GI-1	10413-106B8	60.04	31.34	0.00	5.27	5.27	0.88	1.46	0.88
globus pallidus - adult, donor10196	10175-103C4	5.10	12.39	0.00	0.00	0.73	0.00	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	12.20	22.46	0.00	0.49	0.73	0.49	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	1.37	12.32	0.00	1.37	4.11	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	10.13	23.98	0.00	1.07	5.33	1.07	0.00	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	222.69	39.15	0.00	0.00	7.34	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	14.40	5.12	0.00	0.32	0.32	0.32	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	13.31	8.26	0.00	2.30	2.30	1.38	0.92	0.46
hIPS +CCl2, biol_rep2	14384-156C1	10.97	6.40	0.00	3.20	1.37	0.91	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	16.10	6.44	0.00	1.29	2.58	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	2.87	1.44	0.00	0.00	0.00	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	5.49	4.80	0.00	1.37	4.12	0.69	0.69	0.69
hIPS, biol_rep3	14382-156B8	7.72	15.45	0.00	2.21	2.21	0.00	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	29.31	24.42	0.00	2.59	1.44	0.86	0.29	0.29
heart - mitral valve, adult	10205-103F7	5.38	14.35	0.00	0.00	0.60	0.30	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	6.01	8.11	0.00	0.52	0.00	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	5.83	9.99	0.00	1.67	0.83	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	6.33	8.57	0.00	0.82	0.20	0.41	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	7.24	4.68	0.00	0.43	0.43	0.00	0.43	0.00
heart, adult, pool1	10016-101C7	6.44	7.59	0.00	0.00	0.46	0.23	0.00	0.00
heart, fetal, pool1	10046-101G1	25.05	12.32	0.00	0.92	0.72	0.21	0.21	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	34.55	29.31	0.00	1.54	0.93	0.00	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	8.32	15.46	0.00	0.00	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	50.72	60.22	0.00	4.20	3.87	2.32	0.88	2.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	59.84	64.21	0.00	3.64	3.28	2.79	1.46	1.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	56.79	70.64	0.00	5.56	4.04	2.63	0.91	1.11
hepatoma cell line:Li-7	10484-107A7	7.45	8.23	0.00	0.89	1.11	0.22	0.22	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	3.62	3.22	0.00	0.10	0.60	0.10	0.10	0.10
hippocampus - adult, donor10196	10169-103B7	16.09	17.03	0.00	0.95	2.84	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	18.37	30.82	0.00	1.63	2.45	0.20	0.41	0.20
hippocampus, adult, donor10258	10374-105G5	3.49	10.46	0.00	1.99	4.48	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	12.69	34.54	0.00	1.06	4.93	0.00	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	25.63	6.10	0.00	1.83	3.66	1.22	1.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	29.26	15.32	0.00	3.14	3.34	0.39	0.79	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	27.93	16.76	0.00	3.05	4.06	0.25	0.51	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	37.22	13.53	0.00	6.20	1.69	1.69	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	43.38	18.07	0.00	11.62	3.61	3.87	2.84	2.58
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	31.51	11.39	0.00	8.35	2.66	4.18	1.14	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	44.67	15.18	0.00	3.80	3.50	1.17	1.46	1.75
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	50.19	19.60	0.00	4.09	3.66	1.72	1.94	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	40.04	18.35	0.00	2.92	1.67	1.67	1.67	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	34.57	15.87	0.00	1.42	1.89	0.24	0.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	49.02	22.34	0.00	5.46	3.05	1.77	2.09	2.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	35.01	16.83	0.00	2.02	3.37	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	26.60	21.13	0.00	5.16	2.50	1.25	1.56	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	22.60	16.70	0.00	0.49	1.47	1.47	2.46	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.98	5.24	0.00	1.75	1.75	0.00	2.62	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	56.70	29.59	0.00	8.59	2.48	1.53	2.10	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	50.15	25.29	0.00	3.05	3.05	2.18	1.31	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	39.48	12.99	0.00	10.00	3.50	2.00	2.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	45.59	24.30	0.00	5.46	3.20	1.70	2.45	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	35.01	21.83	0.00	8.64	3.64	0.91	0.45	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	41.97	14.41	0.31	5.64	4.70	1.57	0.63	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	50.46	23.84	0.16	7.84	2.61	1.63	1.80	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	50.22	27.00	0.00	6.68	3.77	0.87	2.61	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	50.52	25.41	0.00	7.17	1.49	0.90	2.39	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	27.53	18.84	0.00	2.96	2.22	1.85	0.92	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	30.53	17.69	0.00	3.42	4.28	0.86	0.86	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	22.05	5.72	0.00	4.90	3.67	0.41	1.63	3.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	42.95	16.20	0.00	7.75	5.99	2.11	1.41	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	47.19	22.17	0.00	9.82	2.53	2.85	2.53	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	44.18	13.92	0.00	7.87	3.33	3.63	2.42	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	38.78	17.07	0.00	5.69	4.14	0.52	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	34.54	16.60	0.00	3.98	5.98	0.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	34.12	13.60	0.00	2.31	2.05	1.03	1.03	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	44.74	22.50	0.00	4.60	5.37	2.05	2.56	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	40.13	19.69	0.00	3.79	1.51	1.51	0.76	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	44.02	18.15	0.00	5.71	3.02	1.68	0.67	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	27.29	20.53	0.00	3.62	2.90	0.97	0.97	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	18.72	6.24	0.00	2.67	0.89	0.89	0.45	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	23.41	11.22	0.00	2.44	2.93	1.95	2.44	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	56.23	19.87	0.00	5.81	3.97	3.97	3.97	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3.25	0.00	0.00	9.76	0.00	3.25	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	36.73	10.92	0.00	12.91	2.32	1.65	1.99	2.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	43.78	15.87	0.00	8.76	3.28	0.00	0.55	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	42.70	14.84	0.00	4.34	1.45	1.09	2.90	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	25.98	11.03	0.00	3.91	2.49	0.71	2.49	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	29.83	9.55	0.00	4.77	0.00	4.77	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	53.22	21.94	0.00	10.56	2.98	0.95	1.49	1.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	31.79	14.82	0.00	3.77	2.16	0.81	1.35	0.54
immature langerhans cells, donor1	11904-125F5	10.90	6.78	0.00	0.00	0.24	0.24	0.24	0.00
immature langerhans cells, donor2	11905-125F6	12.67	11.09	0.00	0.00	0.79	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	25.65	42.59	0.09	2.56	6.44	0.57	0.76	0.85
keratoacanthoma cell line:HKA-1	10791-110H8	8.78	8.78	0.00	0.33	1.63	0.33	0.65	0.00
kidney, adult, pool1	10017-101C8	9.91	50.66	0.00	2.70	1.50	1.30	0.70	0.60
kidney, fetal, pool1	10045-101F9	43.15	54.75	0.00	2.76	2.05	0.85	0.50	0.64
large cell lung carcinoma cell line:IA-LM	10509-107D5	10.37	4.97	0.00	0.28	1.28	0.00	0.00	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	2.76	1.24	0.00	0.28	0.00	0.00	0.28	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	7.71	6.79	0.00	0.18	0.00	0.00	0.18	0.00
left atrium, adult, donor1	10079-102A7	11.44	11.44	0.00	1.09	1.09	1.09	0.00	0.00
left ventricle, adult, donor1	10078-102A6	5.06	7.58	0.00	0.51	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	24.90	12.59	0.00	0.00	1.09	0.82	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	10.42	14.37	0.00	1.80	0.72	0.72	0.72	1.44
leiomyoma cell line:15242A	10570-108B3	8.15	13.59	0.00	1.09	2.17	1.63	0.54	0.00
leiomyoma cell line:15425	10571-108B4	11.66	17.00	0.00	2.43	1.21	0.73	1.21	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	26.14	21.96	0.00	0.00	1.05	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	2.48	0.83	0.00	0.00	0.00	0.12	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	31.87	26.40	0.00	2.03	3.12	0.78	0.31	0.78
liposarcoma cell line:SW 872	10726-110A6	50.56	31.56	0.00	1.10	3.29	0.73	0.73	0.49
liver, adult, pool1	10018-101C9	16.21	30.79	0.00	7.29	1.62	1.30	1.30	0.49
liver, fetal, pool1	10086-102B5	19.75	17.87	0.00	0.94	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	8.90	21.00	0.00	0.73	1.31	0.44	0.29	0.15
locus coeruleus, adult, donor10252	10165-103B3	10.15	19.93	0.00	1.11	1.11	0.55	0.18	0.37
locus coeruleus, adult, donor10258	10375-105G6	7.05	17.77	0.00	0.28	2.26	0.28	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	7.57	13.04	0.00	5.47	1.68	1.26	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	6.50	4.71	0.00	0.00	0.14	0.14	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	41.36	15.86	0.00	2.07	0.69	1.38	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	13.97	5.40	0.00	0.66	0.40	0.26	0.00	0.00
lung, adult, pool1	10019-101D1	12.64	10.16	0.00	1.06	0.24	0.59	0.47	0.00
lung, fetal, donor1	10068-101I5	11.13	10.56	0.00	0.57	0.29	0.57	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	8.25	17.41	0.00	2.75	0.00	0.46	0.92	0.46
lymph node, adult, donor1	10077-102A5	13.25	37.87	0.00	2.37	0.95	0.95	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	1.32	0.22	0.00	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	9.66	3.02	0.00	0.00	0.15	0.15	0.00	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	9.34	9.34	0.00	0.85	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	5.33	1.78	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	5.60	6.23	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	4.27	2.84	0.00	0.24	0.00	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	1.32	2.37	0.00	0.00	0.00	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	23.11	18.11	0.71	1.91	0.71	0.24	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	13.54	21.43	0.00	2.26	2.26	2.26	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	12.51	23.17	0.00	1.29	1.29	1.29	0.74	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	14.61	13.66	0.00	0.32	2.54	0.64	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	8.10	3.84	0.00	1.71	2.56	1.71	1.28	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	18.56	23.79	0.00	3.38	1.86	1.18	1.35	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	14.64	25.04	0.00	2.97	0.64	0.21	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	19.26	0.00	0.00	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	24.41	44.51	0.36	0.36	6.82	0.72	1.08	0.36
medulla oblongata - adult, donor10196	10174-103C3	9.73	11.68	0.00	0.65	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	13.16	19.04	0.00	1.24	1.24	0.46	0.00	0.15
medulla oblongata, adult, pool1	10038-101F2	11.35	17.22	0.08	0.65	1.47	0.33	0.24	0.08
medulla oblongata, newborn, donor10223	10361-105F1	5.55	11.46	0.00	1.04	1.04	0.35	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	20.81	5.31	0.00	1.11	0.66	0.00	0.44	0.44
medulloblastoma cell line:ONS-76	10759-110E3	40.47	32.28	0.00	0.98	3.67	0.37	0.37	0.12
melanoma cell line:COLO 679	10514-107E1	16.96	6.47	3.88	2.16	0.29	0.29	0.29	0.43
melanoma cell line:G-361	10465-106H6	87.14	210.65	168.04	50.22	11.13	9.50	14.66	5.16
meningioma cell line:HKBMM	10691-109F7	8.32	5.43	0.00	0.36	0.36	0.36	0.18	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	32.60	13.22	0.00	0.88	0.00	1.76	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	48.22	18.66	0.00	1.56	2.07	1.30	0.26	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	19.18	22.25	0.00	1.23	1.99	0.61	0.46	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	14.00	21.45	0.00	2.18	0.91	0.36	0.36	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	5.80	14.49	0.00	0.83	1.24	0.00	0.83	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	13.77	23.04	0.00	1.97	1.97	0.42	0.28	1.12
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	14.83	16.95	0.00	1.54	0.58	0.96	0.58	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.19	19.43	0.00	0.69	2.08	1.39	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	8.75	15.96	0.00	1.72	1.72	0.69	0.34	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	15.87	16.10	0.00	2.07	1.73	0.58	0.69	0.92
mesenchymal precursor cell - cardiac, donor3	11754-123G8	23.34	30.90	0.00	2.12	2.25	0.27	0.66	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	23.36	26.74	0.00	2.30	1.35	0.41	0.54	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	24.47	25.04	0.00	2.70	1.85	1.00	0.71	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	17.13	14.49	0.00	0.66	1.32	0.66	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	25.05	21.45	0.00	0.83	1.52	0.83	0.42	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	16.06	12.57	0.00	3.14	1.75	0.70	0.35	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	11.84	10.21	0.00	0.82	0.82	0.61	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	16.89	23.72	0.00	2.88	1.80	0.36	0.36	1.80
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	12.62	7.24	0.00	1.14	0.52	0.41	0.21	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	14.14	10.94	0.00	1.60	0.68	0.00	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	9.23	14.68	0.00	1.26	0.84	0.00	1.68	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	27.80	32.13	0.00	1.64	2.39	0.60	0.15	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	20.13	24.60	0.00	1.31	2.28	0.61	0.79	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	21.72	13.25	0.00	1.47	2.21	0.74	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	20.32	15.45	0.00	2.00	0.29	0.86	0.86	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	18.10	9.68	0.00	2.11	0.42	1.68	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	19.64	31.05	0.00	0.46	2.28	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	18.16	25.32	0.00	2.05	0.77	0.00	0.51	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	21.46	27.75	0.00	3.40	1.31	0.79	1.83	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	20.64	18.49	0.00	1.85	1.54	0.92	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	16.00	15.30	0.00	1.88	0.71	0.47	3.29	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	19.63	20.31	0.00	2.71	1.35	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	18.86	13.75	0.00	1.57	0.79	0.00	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	18.07	18.07	0.00	1.85	0.46	0.46	1.85	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	20.77	28.26	0.00	3.75	1.44	0.58	0.87	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	18.52	21.86	0.00	1.34	0.67	0.45	0.45	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	21.15	26.44	0.00	2.64	2.40	0.96	0.24	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	23.47	17.60	0.00	1.47	0.00	0.00	0.00	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	20.14	18.13	0.00	2.35	2.01	0.00	1.01	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.92	18.83	0.00	2.87	0.82	0.00	1.23	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	17.18	15.89	0.00	2.15	1.72	0.86	0.43	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	30.08	0.00	0.00	2.73	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	15.49	0.00	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	17.54	23.71	0.00	0.97	0.97	0.65	0.32	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	21.82	17.46	0.00	2.91	0.00	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	18.12	27.19	0.00	0.00	1.07	1.07	0.00	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	12.27	22.08	0.00	0.00	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	20.60	28.77	0.00	0.78	1.55	0.00	0.00	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	12.59	0.00	0.00	2.10	4.20	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	16.89	15.90	0.00	0.00	0.99	0.99	1.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	23.84	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	16.01	17.20	0.00	0.59	1.19	0.00	1.19	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	14.62	23.15	0.00	0.00	2.44	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	24.70	19.63	0.00	0.00	0.63	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	10.00	10.00	0.00	0.69	0.34	0.00	0.34	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	6.45	0.00	0.00	0.00	2.15	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	11.98	0.00	0.00	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	3.44	0.00	3.44	0.00	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.93	6.52	0.00	0.81	0.81	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.15	7.94	0.00	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.61	10.61	0.00	0.59	0.59	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	8.73	7.48	0.00	0.00	0.31	0.31	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	13.37	8.02	0.00	2.67	2.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	16.56	15.37	0.00	0.00	4.73	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	10.27	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	16.52	13.77	0.00	2.07	2.75	0.00	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	13.36	9.90	0.00	1.48	0.49	0.00	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	13.46	0.00	0.00	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	9.54	11.45	0.00	0.00	1.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	16.52	10.88	0.00	0.00	0.81	0.40	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	6.54	0.00	2.18	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	7.60	13.94	0.00	1.27	1.27	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	4.25	1.82	0.00	0.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	2.47	1.65	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	11.11	17.26	0.00	0.00	0.99	0.20	0.40	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	13.95	15.25	0.00	0.65	0.97	0.65	0.00	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	17.32	23.43	0.00	1.02	1.02	0.00	3.06	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	18.57	6.96	0.00	0.00	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	15.83	5.67	0.00	0.47	0.71	0.00	0.24	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	27.34	25.72	0.00	1.16	1.62	0.70	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	4.27	0.00	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	3.90	2.77	0.00	0.41	0.72	0.00	0.10	0.21
mesothelioma cell line:Mero-25	10850-111F4	5.67	5.90	0.00	0.23	0.23	0.00	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	20.78	15.16	0.00	1.71	0.98	0.49	0.98	1.71
mesothelioma cell line:Mero-48a	10852-111F6	19.26	13.51	0.00	0.89	1.11	0.89	0.22	0.66
mesothelioma cell line:Mero-82	10853-111F7	9.72	8.41	0.00	0.79	1.58	0.00	0.26	0.53
mesothelioma cell line:Mero-83	10854-111F8	8.00	9.53	0.00	1.36	1.19	0.17	0.68	0.34
mesothelioma cell line:Mero-84	10855-111F9	10.11	11.12	0.00	0.51	1.01	0.25	0.25	0.76
mesothelioma cell line:Mero-95	10856-111G1	30.85	22.15	0.00	2.48	2.48	1.04	1.04	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	10.10	10.44	0.00	1.16	0.99	0.83	0.33	0.66
mesothelioma cell line:NCI-H226	10846-111E9	18.46	26.24	0.00	1.99	1.81	0.36	0.36	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	17.59	24.43	0.00	2.56	1.71	0.68	1.02	1.20
mesothelioma cell line:NCI-H28	10845-111E8	13.23	10.69	0.00	1.02	0.76	0.51	0.51	0.25
mesothelioma cell line:No36	10857-111G2	8.81	18.27	0.00	0.00	1.30	0.98	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	17.07	20.32	0.00	1.08	2.17	0.27	0.81	1.35
migratory langerhans cells, donor1	11901-125F2	10.17	5.76	2.11	0.77	0.19	0.77	0.19	1.34
migratory langerhans cells, donor2	11902-125F3	20.88	20.03	0.73	0.61	0.12	0.24	0.73	0.73
migratory langerhans cells, donor3	11903-125F4	14.00	9.87	2.15	0.54	0.18	0.36	0.36	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	20.57	21.22	0.00	2.61	3.26	1.31	1.96	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	13.56	8.27	0.00	0.64	0.64	0.64	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	7.83	10.37	0.00	0.69	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	23.03	26.26	0.00	1.52	1.52	0.57	0.38	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	23.47	10.35	0.00	1.11	1.11	0.00	0.00	0.37
myeloma cell line:PCM6	10474-106I6	2.77	0.79	0.00	0.20	0.20	0.20	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	29.42	13.19	0.00	1.52	0.00	0.51	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	19.81	22.56	0.00	0.78	1.37	0.20	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	6.57	6.35	0.00	0.11	0.11	0.00	0.22	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	5.15	2.65	0.00	0.15	0.44	0.00	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	32.02	19.32	0.00	0.55	0.55	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	62.12	8.51	0.00	1.15	0.00	0.46	0.69	0.92
neuroblastoma cell line:NB-1	10539-107G8	30.31	7.48	0.00	0.75	0.94	0.19	0.56	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	39.23	14.55	0.00	1.69	3.37	0.63	1.05	0.84
neuroblastoma cell line:NH-12	10555-107I6	75.29	13.98	0.00	1.12	0.56	0.93	0.37	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	19.69	6.17	0.00	1.19	0.95	0.24	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	20.43	17.11	0.00	1.27	2.22	0.48	0.48	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	67.62	35.42	0.00	1.01	7.45	0.20	1.01	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	46.41	18.44	0.00	1.27	1.27	0.64	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	31.94	27.95	0.00	0.80	2.66	0.27	0.53	0.00
neutrophil PMN, donor1	12133-128D9	74.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	45.83	11.84	0.00	1.01	0.51	0.68	0.34	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	10.41	0.80	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	35.59	31.10	0.00	3.21	2.89	0.32	1.28	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	32.06	23.65	0.00	2.36	1.05	0.79	1.05	1.31
nucleus accumbens, adult, pool1	10037-101F1	19.87	30.84	0.00	3.09	3.28	0.47	0.09	0.47
occipital cortex - adult, donor10196	10172-103C1	12.36	20.60	0.00	0.00	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	13.69	24.69	0.00	1.61	0.00	1.07	0.54	0.00
occipital cortex, newborn, donor10223	10355-105E4	20.38	48.77	0.00	2.18	4.37	2.18	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	14.17	22.83	0.00	1.31	3.94	0.79	0.79	0.00
occipital lobe, fetal, donor1	10073-102A1	131.73	78.10	0.00	2.57	5.58	0.43	1.72	1.72
occipital pole, adult, pool1	10036-101E9	22.23	32.88	0.00	1.89	4.02	0.87	0.55	0.32
olfactory region, adult	10195-103E6	8.79	22.16	0.00	2.29	1.91	0.19	0.19	0.38
optic nerve, donor1	10277-104E7	4.00	12.01	0.00	4.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	7.86	15.26	0.00	1.25	1.82	0.23	0.57	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	14.15	2.20	0.00	0.41	0.00	0.14	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	7.11	7.79	0.00	0.68	0.51	0.34	0.51	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	12.82	9.47	0.00	1.16	0.46	0.35	0.46	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	7.94	3.82	0.00	0.59	0.88	0.59	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	44.85	14.02	0.00	0.00	0.00	1.87	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	24.39	16.75	0.42	0.64	3.39	0.85	0.00	0.64
ovary, adult, pool1	10020-101D2	11.09	9.78	0.00	1.92	0.35	0.09	0.35	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	28.23	15.03	0.00	1.47	0.18	1.10	0.37	0.18
pancreas, adult, donor1	10049-101G4	0.94	0.94	0.00	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	4.75	2.24	0.00	0.28	0.00	0.00	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	14.31	15.50	0.00	1.87	1.70	0.85	0.68	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	25.17	9.27	0.00	1.32	0.50	0.83	0.50	0.33
paracentral gyrus, adult, pool1	10035-101E8	20.96	31.94	0.00	1.74	3.75	0.55	0.37	0.46
parietal cortex, adult, donor10258	10373-105G4	16.88	19.08	0.00	2.20	3.67	2.20	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	16.93	13.17	0.00	0.94	1.88	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	13.97	24.23	0.00	2.00	0.86	0.86	0.57	0.86
parietal lobe, adult, pool1	10034-101E7	22.38	32.43	0.00	0.97	4.23	0.26	0.35	0.18
parietal lobe, fetal, donor1	10072-101I9	102.80	76.62	0.00	5.82	3.88	2.91	2.91	4.85
parietal lobe, newborn, donor10223	10356-105E5	21.68	28.41	0.00	0.75	5.61	1.50	0.00	0.37
parotid gland, adult	10199-103F1	5.55	8.63	0.00	0.62	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	8.59	5.37	0.54	1.61	0.54	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	5.21	3.90	0.00	0.19	0.19	0.37	0.37	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	38.75	25.21	0.00	0.87	3.79	0.29	0.87	0.15
pineal gland - adult, donor10196	10179-103C8	14.84	13.55	0.00	0.65	1.94	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	14.21	18.36	0.00	0.00	1.18	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	6.27	9.41	0.00	1.25	1.25	0.00	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	7.08	6.07	0.00	2.02	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	10.94	9.90	0.00	2.61	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	2.55	3.40	0.00	1.70	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	12.47	12.47	0.00	1.51	0.22	0.11	0.11	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	14.30	15.10	0.00	0.93	0.66	0.40	0.66	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	44.05	26.61	0.00	1.09	0.62	0.16	0.31	0.62
pons, adult, pool1	10033-101E6	9.12	12.31	0.00	0.52	1.29	0.26	0.17	0.34
postcentral gyrus, adult, pool1	10032-101E5	22.06	33.56	0.00	2.27	4.18	0.78	0.61	0.96
promyelocytes/myelocytes PMC, donor1	12132-128D8	66.92	6.27	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	9.18	3.50	0.00	0.44	0.44	0.15	0.29	0.15
prostate cancer cell line:PC-3	10439-106E7	20.87	15.06	0.00	0.73	1.63	0.18	0.18	0.00
prostate, adult, pool1	10022-101D4	10.52	9.70	0.00	0.82	0.36	0.27	0.18	0.18
putamen, adult, donor10196	10176-103C5	14.87	31.16	0.00	1.65	1.89	0.94	0.00	0.24
putamen, adult, donor10252	10152-102I8	3.92	25.49	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	6.56	0.00	0.00	0.00	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	9.42	19.09	0.00	1.21	0.97	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	3.00	6.75	0.00	4.50	2.25	0.75	3.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	21.82	4.36	0.00	0.58	0.29	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	52.86	38.95	0.00	0.00	1.39	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	25.02	30.53	0.00	1.70	1.06	1.06	1.06	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	21.12	17.40	0.00	0.83	0.41	2.07	1.24	1.24
retina, adult, pool1	10030-101E3	14.21	13.22	1.09	0.60	0.70	0.20	0.10	0.20
retinoblastoma cell line:Y79	10475-106I7	32.48	5.98	0.00	1.04	0.52	0.52	0.52	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	12.91	11.56	0.00	0.25	1.35	0.49	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	46.12	15.75	0.00	0.56	0.28	0.56	0.28	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	40.17	26.52	0.00	0.00	2.27	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	7.61	9.55	0.00	0.65	1.29	0.32	0.32	0.32
salivary acinar cells, donor2	11772-123I8	6.61	13.22	0.00	1.38	1.38	0.41	0.14	0.41
salivary acinar cells, donor3	11773-123I9	7.28	9.27	0.00	0.00	0.00	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	4.00	9.15	0.00	1.72	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	6.07	10.62	0.00	1.10	2.70	0.25	0.51	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	8.23	13.87	0.00	0.71	1.65	0.12	0.12	0.00
seminal vesicle, adult	10201-103F3	5.29	7.94	0.00	0.53	0.00	0.00	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	7.53	2.92	0.00	0.00	0.24	0.24	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	12.58	15.10	0.00	1.01	0.25	0.25	0.50	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	8.03	9.03	0.00	2.01	0.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	18.00	19.48	0.00	0.67	1.07	0.54	0.81	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	22.77	43.77	0.00	2.21	3.43	0.33	0.77	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	28.13	49.16	0.00	1.29	1.81	0.77	1.03	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	2.84	2.84	0.00	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	2.88	2.64	0.00	0.00	0.00	0.00	0.36	0.00
skeletal muscle, fetal, donor1	10066-101I3	31.16	23.12	0.00	2.01	1.01	0.00	0.00	2.01
skin, adult, donor1	10074-102A2	0.00	13.57	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	25.88	17.04	0.63	0.63	0.63	2.52	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	8.00	6.67	0.00	0.00	1.00	0.00	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	49.17	11.35	0.00	2.21	0.95	1.89	2.21	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	29.30	4.82	0.00	1.16	0.58	0.58	0.77	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	14.67	5.93	0.00	0.82	0.66	0.16	0.33	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	17.21	0.64	0.00	0.97	0.00	0.32	0.00	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	22.23	12.20	0.00	0.87	1.74	0.44	0.22	1.09
small intestine, adult, pool1	10024-101D6	16.12	26.16	0.00	5.02	0.96	0.60	1.07	0.12
small intestine, fetal, donor1	10064-101I1	46.68	54.30	0.00	3.93	2.21	1.97	0.98	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	16.41	4.62	0.00	1.03	0.51	0.00	1.03	0.00
smooth muscle, adult, pool1	10048-101G3	6.98	6.72	0.00	0.52	0.26	0.00	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	23.59	6.16	0.00	1.34	0.54	0.00	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	13.08	17.66	0.00	0.23	0.46	0.92	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	10.25	18.14	0.00	0.39	0.00	0.00	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	2.08	1.38	0.00	0.00	0.69	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	24.39	42.08	0.00	0.61	4.27	0.61	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	4.59	5.51	0.00	0.92	0.92	0.46	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	19.42	11.80	0.00	0.45	0.30	0.75	0.15	0.30
spleen, adult, pool1	10025-101D7	17.18	31.94	0.00	5.29	1.54	0.99	0.77	0.22
spleen, fetal, pool1	10044-101F8	37.50	52.68	0.00	2.62	2.46	0.95	0.56	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	6.94	11.28	0.00	0.52	0.62	0.10	0.10	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	11.77	5.70	0.00	0.00	0.19	0.19	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	5.24	6.29	0.00	0.35	0.35	0.35	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	9.38	12.51	0.00	0.00	0.39	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	11.59	9.12	0.00	0.34	0.79	0.11	0.11	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	0.85	2.12	0.00	0.42	0.00	0.00	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	24.96	14.81	0.00	0.85	0.00	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	24.56	23.50	0.00	0.00	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	7.41	5.70	0.00	0.00	0.00	0.00	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	9.97	20.36	0.00	1.25	0.42	0.62	0.00	0.42
substantia nigra, adult, donor10258	10371-105G2	3.62	7.24	0.00	1.55	2.59	1.03	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	4.95	9.89	0.00	1.41	0.71	0.71	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	49.75	20.63	0.00	1.38	0.46	1.15	0.23	0.69
temporal lobe, adult, pool1	10031-101E4	27.21	43.49	0.00	2.54	4.41	1.19	0.68	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	94.73	63.39	0.00	4.27	9.26	2.14	3.56	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	70.77	42.20	0.00	2.20	5.71	2.64	1.76	2.64
tenocyte, donor1	11763-123H8	44.68	55.16	0.00	7.33	2.09	3.14	1.75	1.75
tenocyte, donor2	11765-123I1	22.13	23.27	0.00	1.53	1.14	0.00	0.76	0.76
tenocyte, donor3	11768-123I4	21.87	21.13	0.00	1.11	1.85	0.37	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	43.68	22.77	0.00	2.38	4.93	1.70	0.51	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	48.71	16.65	0.00	3.24	1.85	0.77	0.62	1.08
teratocarcinoma cell line:PA-1	10807-111A6	36.73	22.78	0.00	1.08	7.13	0.77	0.31	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	29.07	29.83	0.00	2.41	4.95	0.51	1.02	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	27.23	17.77	0.00	2.27	3.40	1.13	1.51	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	14.07	16.69	1.64	1.64	2.40	0.44	0.22	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	32.90	24.75	0.00	3.91	2.61	2.93	1.63	3.26
testis, adult, pool1	10026-101D8	12.46	16.32	0.00	5.05	2.36	0.21	0.75	0.11
testis, adult, pool2	10096-102C6	13.53	16.24	0.00	0.90	2.26	0.90	1.35	0.90
thalamus - adult, donor10196	10168-103B6	12.14	20.98	0.00	1.10	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	10.78	14.85	0.00	0.94	0.47	0.63	0.16	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	3.08	10.78	0.00	1.54	9.24	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	7.91	19.27	0.00	0.66	2.80	0.33	0.33	0.16
thalamus, newborn, donor10223	10366-105F6	9.78	10.93	0.00	1.15	6.90	1.15	0.58	0.00
throat, adult	10209-103G2	3.25	8.49	0.00	0.50	0.50	0.00	0.00	0.00
throat, fetal, donor1	10061-101H7	25.90	20.11	0.00	0.91	0.61	0.91	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	9.74	4.57	0.00	0.40	0.99	0.00	0.40	0.00
thymus, adult, pool1	10027-101D9	17.40	10.04	0.00	2.78	0.40	0.50	0.80	0.60
thymus, fetal, pool1	10043-101F7	26.18	18.50	0.00	1.97	0.21	1.14	0.31	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	11.83	13.69	0.00	0.93	0.27	0.27	0.53	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	10.06	8.66	0.00	0.42	0.70	0.14	0.14	0.28
thyroid, adult, pool1	10028-101E1	5.88	12.13	0.00	0.56	0.37	0.09	0.09	0.09
thyroid, fetal, donor1	10060-101H6	22.68	38.49	0.00	0.53	2.11	1.32	0.53	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	3.08	0.00	0.00	0.00	0.00	3.08	3.08
tongue, adult	10203-103F5	3.72	4.19	0.00	0.00	0.00	0.70	0.23	0.70
tongue, fetal, donor1	10059-101H5	14.19	16.95	0.00	1.18	0.00	0.39	1.97	0.00
tonsil, adult, pool1	10047-101G2	11.52	12.12	0.00	0.30	0.40	0.10	0.20	0.00
trachea, adult, pool1	10029-101E2	12.43	18.40	0.00	2.04	0.65	0.41	0.25	0.16
trachea, fetal, donor1	10058-101H4	16.16	20.39	0.00	0.77	1.15	0.00	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	18.42	24.09	0.00	0.71	1.77	1.06	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	53.09	30.09	0.00	1.22	2.53	0.91	0.51	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	4.86	3.13	0.00	0.31	0.31	0.16	0.16	0.00
tridermal teratoma cell line:HGRT	10694-109G1	104.64	45.66	0.00	1.90	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	13.37	9.48	0.00	0.85	0.93	0.00	0.00	0.25
umbilical cord, fetal, donor1	10057-101H3	20.87	4.17	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	8.70	7.17	0.00	0.51	0.17	0.00	0.00	0.00
uterus, fetal, donor1	10055-101H1	32.25	20.48	0.00	1.54	4.10	0.51	0.00	0.00
vagina, adult	10204-103F6	9.05	8.40	0.00	0.00	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	10.96	21.92	0.00	3.07	0.00	0.22	0.66	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	7.48	4.81	0.00	0.00	0.00	0.00	0.00	0.53